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Optimal management of British military personnel injured in Afghanistan is best 
achieved in the United Kingdom; therefore aeromedical evacuation (AE) is 
arranged, often within the first 24 hours for the most severely injured casualties.  
However, early aeromedical evacuation carries its own risks, which must be 
considered prior to emplaning any casualty.  The aim of this study was to 
investigate whether changes in tissue oxygenation occur in military casualties 
during aeromedical evacuation.  Near infra-red spectroscopy was used in a series 
of studies designed to test the sensitivity of the  tissue oxygen saturation 
monitoring technique in volunteers exposed to simulated altitude and simulated 
hypovolaemia.  Changes in tissue oxygen saturation readings were detected in the 
volunteers, so an observational study was undertaken to determine whether 
changes in tissue oxygen saturation occur in military trauma casualties during 
aeromedical evacuation.  Whilst the majority of casualties did not demonstrate 
any significant change in readings, some casualties did demonstrate reduced tissue 
oxygen saturation readings during their flights, although these changes were not 
reflected in systemic physiological monitoring techniques.  Having identified that 
changes do occur, further work is required to investigate the cause, significance 
and outcome of these changes in order to fully appreciate the findings of the 
current study.          
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Aeromedical evacuation (AE) is defined by the Royal Air Force as the 
movement of patients under medical supervision to and between medical 
treatment facilities by air transportation (MoD, 2007).  This study focuses on the 
movement of military casualties from the British Field Hospital at Camp Bastion, 
in Helmand Province, Afghanistan, back to the Royal Centre of Defence Medicine 
(RCDM), which is based at the Queen Elizabeth Hospital, Birmingham.  British 
military personnel injured in Afghanistan are initially transferred to a field 
hospital facility for resuscitation and primary surgical intervention.  Once 
stabilised, optimal management of these patients is best achieved in the United 
Kingdom (UK), therefore early aeromedical evacuation is arranged, often within 
the first 12 hours for the most severely injured casualties. 
The development of military aeromedical evacuation flights can be traced 
back to the First World War.  A French Medical Officer, Eugene Chassaing, 
modified military aircraft to operate as air ambulances, transporting wounded 
soldiers (Coker, 2006).  Development of AE continued after the end of the First 
World War, with the addition of medically trained escorts to provide in-flight care 
for the evacuated casualties (Vanderburg, 2003). 
Since these early beginnings, aeromedical evacuation has continued to 
advance; contemporary UK military AE flights can be undertaken in a wide range 
of fixed or rotary wing aircraft, according to the patient load, location and severity 
of their illness/injuries.  Medical escorts for military AE flights will also vary 
according to the needs of the patient and can range from a Flight Medic (FM), 
offering minimal intervention, to a full Critical Care Air Support Team (CCAST), 





providing complete intensive care management in-flight.  Although it is desirable 
to provide early management of the casualties in the UK medical system, 
aeromedical evacuation carries its own risks, which must be considered before the 
patient is emplaned.  This study will focus on some of the potential risks 
associated with aeromedical evacuation of acutely injured military personnel. 
 
1.1. Hypobaric Hypoxia 
 
Military aeromedical evacuation from the current operational settings may 
be undertaken in a variety of fixed wing aircraft.  Irrespective of aircraft type, the 
cabin will be pressurised to an altitude between 6,000 and 8,000 feet (ft) (1829 to 
2438 metres (m)), unless there is a specific medical reason for a ground level 
cabin altitude
1
.  Although the aircraft is actually cruising at a much higher altitude 
(>30,000 feet or 9144m), the physiological effects on the crew and passengers at 
these altitudes would be fatal; 8,000 feet is commonly the maximum permitted 
cabin pressurisation in military and commercial passenger aircraft, to ensure the 
safety and well-being of all on board.    
At sea level, barometric pressure is approximately 760mmHg (101kPa).  
Barometric pressure falls with increasing altitude; at 8,000 feet, barometric 
pressure is reduced to 565mmHg, which is significant because the partial pressure 
of oxygen also decreases as a result.  According to Dalton’s Law, the pressure of a 
mixture of gases is equal to the sum of the partial pressures of the individual gases 
in the mixture.  Oxygen forms approximately 21% of ambient air, so at sea level, 
                                                 
1
 In locations above sea level, a ground level cabin altitude is used, as the casualty is already 
accustomed to this altitude.  As an example, Camp Bastion is at an altitude of 3,000ft, so casualties 
requiring a cabin altitude restriction for medical reasons will be transported at or above 3,000ft 
cabin altitude (equal to ground level), not at sea level. 





the approximate partial pressure of oxygen (PO2) is 160mmHg (21.3kPa) (PO2 = 
21/100 x 760).  At 8,000 feet, the partial pressure of oxygen falls to 118mmHg 
(15.7kPa).  Consequently, at altitude, the partial pressure of oxygen in alveolar air 
also falls, which is significant for oxygen carriage throughout the body.  
Haemoglobin binds easily with oxygen to form oxyhaemoglobin and, at sea level, 
is almost completely saturated with oxygen when it leaves the lung.  Lower PO2 in 
the tissues causes the oxygen to dissociate from the haemoglobin, freeing the 
oxygen for use by the tissues.  At altitude, the lowered partial pressure of alveolar 
oxygen (PAO2) results in less saturated molecules of haemoglobin, which results 
in less oxygen availability in the tissues.  Reduced barometric pressure at altitude 
causes a decrease in the partial pressure of oxygen, which, in turn, results in less 
saturated molecules of haemoglobin, which is demonstrated by the 
oxyhaemoglobin dissociation curve at Figure 1.  At sea level, PO2 is 95mmHg, 
which (in healthy individuals) will result in 97% oxyhaemoglobin saturation 
(Gradwell, 2006).  Ascent to an altitude of 8,000ft causes a reduction in PO2 to 
56mmHg and a subsequent fall in oxyhaemoglobin saturation. 
 
Figure 1. Oxyhaemoglobin dissociation curve, demonstrating fall in % saturation with 
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Factors affecting the uptake of oxygen by haemoglobin at the alveolar 
level and the off-loading of oxygen at the tissue level include temperature and 
acidosis/alkalosis.  A right shift of the curve at Figure 1 indicates factors such as 
acidosis, a raised body temperature or hypercapnia, which reduces the uptake of 
oxygen by haemoglobin but increases oxygen release at the cellular level.  A left 
shift of the curve at Figure 1 indicates alkalosis, hypothermia, hypocapnia or 
lower levels of 2,3 diphosphoglycerate (2,3 DPG) in red blood cells.  These 
conditions increase the affinity of haemoglobin to oxygen but the release of 
oxygen at the cellular level consequently occurs at much lower partial pressures 
(Holleran, 1996).  2,3 DPG is a glucose metabolite which assists with the release 
of oxygen from haemoglobin at the cellular level.  Concentrations of 2,3 DPG are 
reduced in stored blood, particularly in blood which has been stored for more than 
2 weeks, so casualties who have had massive blood transfusions may have lower 
levels of 2,3 DPG.  Lumb (2000) suggests that levels of 2,3 DPG in transfused 
blood may not return to normal levels for up to 48 hours post-transfusion.  
Compensatory increases in respiratory rate and cardiac output will ensure 
that most passengers will not experience any significant physiological effects at 
8,000 feet cabin altitude, despite the reduced PAO2, although pulse oximetry will 
show a fall in oxygen saturation from 98-100% to approximately 92%.  
Passengers with underlying medical conditions may not tolerate these 
compensatory mechanisms and may become symptomatic at this altitude, with the 
risk of hypoperfusion of tissues and end organs; this effect must be considered 
when emplaning casualties for aeromedical evacuation (Coker, 2006).  Even 
casualties who are ventilated and sedated throughout their flights will be exposed 





to a lower partial pressure of alveolar oxygen, despite potentially having a higher 
concentration of oxygen administered through the ventilator.  This is because the 
ventilator circuit is only a closed system, not a pressurised system, so the supplied 
gases are subject to the same response as a result of reduced atmospheric pressure. 
Pulse oximetry readings should be interpreted with care in casualties who 
may be acutely anaemic, as the readings may provide false reassurance.  Pulse 
oximetry does not provide any information about the carriage of oxygen around 
the body; fewer haemoglobin molecules in the blood means less oxygen transport, 
but pulse oximetry might show 100% saturation because all of the available 
haemoglobin is fully saturated with oxygen, despite there not being enough 
haemoglobin to meet the body’s oxygen requirements (Martin and Glanfield, 
2006).  
Regional tissue perfusion may be compromised in the critically ill casualty 
as the body diverts blood flow, and therefore oxygen delivery to the vital organs 
at the expense of other tissues.  This may be exacerbated by the use of inotropes 
such as noradrenaline, which may be required to maintain or raise blood flow to 
ensure adequate perfusion of the vital organs.  Even mild tissue hypoxia may have 
a detrimental effect on wound healing.  A lack of oxygen at the tissue level affects 
the production of energy within the body; the combination of oxygen and glucose 
is required to maintain aerobic metabolism.  During anaerobic metabolism, less 
energy is produced but lactic acid and hydrogen ions are also released, leading to 
acidosis within the cells.  Further complex mechanisms are triggered with 
prolonged tissue hypoxia and worsening acidosis, including the release of 
potassium and sodium and hyperglycaemia; if uncorrected, these mechanisms can 





result in damage to the cells or even cell death, leading to organ failure and, 
ultimately, even death of the casualty (Lumb, 2000; Webster, 1999).  
1.2. Anaemic Hypoxia 
 
In recent years, the Defence Medical Services have made rapid progress in 
the immediate management of severe trauma in the operational setting, in 
response to new technological innovations, equipment enhancements and 
improved training provision (MoD, 2006).  As a result of these developments, 
more casualties are surviving the initial traumatic event and consequently require 
urgent AE for life or limb saving management.  Many of the more severely 
injured casualties will have sustained significant haemorrhage at the time of injury 
and may have undergone lengthy surgical procedures.  In order to correct the 
subsequent loss in blood volume, the casualty may have received massive 
transfusions of a variety of blood products.  However, any significant blood loss 
will cause a decrease in haemoglobin levels and, subsequently, the oxygen 
carrying capacity within the body over the short term, as the majority of oxygen is 
transported as oxyhaemoglobin, with only a small proportion dissolved in plasma 
(Schober and Schwarte, 2012). 
To reduce the risk of in-flight deterioration, current protocols (MoD, 2007) 
dictate that casualties undergoing aeromedical evacuation must not be emplaned 
with a haemoglobin level below 7.0 g/dL, although in practice, a cut-off point of 
7.5 g/dL is currently employed, with supplemental oxygen available in-flight for 
these individuals.  The origins of these AE protocols are unclear but they are 
likely to be based on in-hospital experience; haemoglobin results below 10 g/dL 
were traditionally the trigger for red cell transfusions in most western hospitals, 





with little evidence base to support this practice (Ness and Rothko, 1991).  Within 
the current AE protocols it is identified that individuals with acute anaemia as a 
result of recent haemorrhage may become symptomatic in-flight with 
haemoglobin levels up to 10g/dL.  Furthermore, with the rapid evacuation of the 
more severely injured casualties, it is possible that haemoglobin estimates taken 
post transfusion / pre-flight may not be wholly accurate, as the haemoglobin level 
begins to fall several hours after the blood loss and will only stabilise after 2 to 5 
days (de Gruchy, 1989).  Massive and / or repeated transfusions of blood products 
will further complicate / alter the clinical picture in these casualties.  In a recent 
study of Canadian battle-injured personnel, Hannah and Rice (2013) reviewed the 
surgical outcomes for casualties with extremity wounds following aeromedical 
evacuation.  They suggested that the probability of requiring a higher level of 
surgical revision was 37% when the casualty was transported with a haemoglobin 
level of 8g/dL.  This dropped to 20% when the casualty had a pre-flight 
haemoglobin level of 10g/dL.   The findings from this study seem to suggest 
greater tissue damage occurs with the combination of anaemic hypoxia (from low 
haemoglobin levels) and hypoxic hypoxia (from aeromedical evacuation). 
1.3. Near Infra-Red Spectroscopy 
 
 Near infra-red spectroscopy (NIRS) has been used to develop a non-
invasive means of monitoring tissue oxygen saturation.  Sensors applied to the 
skin illuminate the tissues beneath, using light from the near infra-red spectrum 
(680-1000nm).  Near infra-red light readily passes through human tissue; only 3 
substances within the body are known to absorb near infra-red light differently 
according to their concentration within the tissues and according to their 





oxygenation state – haemoglobin, myoglobin and oxidised cytochrome (Creteur, 
2008).  In accordance with the modified Beer-Lambert law, the change in the 
intensity of the light as it passes through the substances indicates the changes in 
the concentration of these substances according to their oxygenation state 
(Boushel and Piantadosi, 2000).  Oxyhaemoglobin and de-oxyhaemoglobin 
absorb near infra-red light at different wavelengths; by measuring the change in 
the wavelengths of the light reflected back to the receiving sensor, the relative 
concentrations of each compound can be calculated.  A receiving sensor gathers 
the portion of the non-absorbed light which passes the sensor as it returns through 
the tissue.  Using specific proprietary algorithms, the various monitors calculate 
the concentrations of oxy- and de-oxyhaemoglobin in the tissues, which are 
primarily used to indicate tissue oxygen saturation (Boushel and Piantadosi, 
2000).  As the technology calculates relative concentrations of each compound, 
tissue oxygen saturation readings should be interpreted as a trend over time rather 
than absolute readings. 
 Ward et al (2006) identify that oxyhaemoglobin and oxymyoglobin absorb 
light at the same wavelength, making it difficult to distinguish between the two 
compounds.  However, the authors suggest that oxymyoglobin releases its oxygen 
at such a low partial pressure that it is saturated for the majority of the time, so 
any changes in regional tissue oxygen saturation seen can be assumed to result 
from changes in the oxygen state of haemoglobin.  A similar situation occurs with 
de-oxyhaemoglobin and de-oxymyoglobin.  Boushel and Piantadosi (2000) 
suggest that even in skeletal muscle, the majority of changes in tissue oxygen 





saturation originate from haemoglobin.  They also suggest that oxidised 
cytochrome makes only a small contribution to any observed changes in readings.  
  
Over the past decade, interest in tissue oxygen saturation monitoring has 
increased.  The ability to predict early changes in regional oxygenation, using a 
non-invasive method suitable for use in the pre-hospital or in-hospital setting is 
very appealing to clinicians.  As a result, a number of companies are now 
marketing tissue oxygen saturation monitors; however, there is no standard 
method of measurement amongst the different commercially available devices; the 
calculation algorithms vary between companies and even the terminology differs 
according to the device used.  A significant number of published studies have 
used the InSpectra
™
 Tissue Oxygenation Monitor, manufactured by Hutchinson 
Technology, who describes tissue oxygen saturation as StO2.  The monitoring 
system being used during the present study is the INVOS
®
 5100C Cerebral / 
Somatic Monitor, manufactured by Somanetics, who describe regional tissue 
oxygen saturation as rSO2.  Within the published studies, the terms appear to be 
used indiscriminately.     
The INVOS system was selected for the present study as it is designed to 
monitor up to four body areas simultaneously
2
; the sensors can be easily applied 
to most areas of the body, allowing more flexibility than some other devices.  It 
utilises “spatially resolved spectroscopy” (Ward et al, 2006), using 2 receiving 
sensors in the same plane (reflectance) but at different distances from the light 
                                                 
2
 At the start of the present study, the aim had been to monitor rSO2 over the deltoid and 
quadriceps muscles, hence the requirement for multi-site monitoring; however, during the study, 
the introduction of topical negative pressure wound dressings prevented monitoring of the lower 
limbs in the majority of patients, as the dressings tended to cover the entire thigh area.    





emitting source; this allows readings to be obtained from within different depths 
of the tissue.  The closest sensor is assumed to receive light passing through 
superficial skin and tissue layers, while the furthest sensor is assumed to receive 
light which has passed through deeper tissue. The INVOS-specific proprietary 
algorithms account for the path lengths of the light obtained from both receiving 
sensors, to ensure only deeper tissue is used in the calculation of tissue oxygen 
saturation. 
As shown in Figure 2, light is emitted from the source and passes through 
the tissue; some of the light will not be picked up by the receiving sensor due to 
its particular path through the tissue, but a portion will be detected by the 2 
receiving sensors, as its particular path is elliptical. 
 
Figure 2. Tissue oxygen saturation monitoring technique  
 
The complexity in determining the actual path length of the light detected 
by the receiving sensors has been discussed by some authors (Soller et al, 2008), 









compartment, so tissue oxygen saturation is actually a reflection of venous 
saturation and therefore perfusion (Keller et al, 2006; Ward et al, 2006; Schober 
and Schwarte, 2012). 
Changes in tissue oxygen saturation readings in the critically ill casualty 
would indicate changes in the regional perfusion of the site being monitored.  
However, treatment protocols implemented to manage the casualty’s condition 
may also affect rSO2 readings, such as the use of inotropes (potentially increasing 
peripheral vasoconstriction) or the induction of anaesthesia (potentially causing 
peripheral vasodilation) (Sheeren et al, 2012), so readings need to be considered 
in context. 
There is little evidence that tissue oxygen saturation monitoring has been 
used to evaluate the effects of altitude in aeromedical evacuation casualties.  Two 
air evacuation studies were identified: Sagraves et al (2009) describe the use of 
tissue oxygen saturation monitoring in the pre-hospital setting, in both ground and 
air ambulances and Guyette et al (2008) describe the use of tissue oxygen 
saturation monitoring in conjunction with lactate monitoring during air transport 
of trauma patients by helicopter.  Neither study considered the effect of altitude; 
probably because air evacuation by helicopter is generally performed over short 
distances at relatively low altitudes, compared with evacuation by fixed wing 
aircraft.  The lack of related studies would suggest that this is a novel use of the 
monitoring system and technique.   
 Several recent studies have monitored tissue oxygen saturation in trauma 
patients to try to identify a reliable end-point for traumatic shock resuscitation.  
McKinley et al (2000) measured oxygen saturation in subcutaneous tissue and in 





skeletal muscle in 8 severely injured casualties during and following the initiation 
of a standardised resuscitation protocol.  Skeletal muscle oxygen saturation 
increased significantly during the 24 hour monitoring period, as local perfusion 
improved, in response to the administration of blood products and supplemental 
oxygen; however, subcutaneous tissue readings were higher and remained fairly 
constant throughout the resuscitation period.  In this study, skeletal muscle tissue 
oxygen saturation appeared to correlate with arterial base deficit and lactate 
measurements, which are accepted end resuscitation points already.    
Cohn et al (2007) collected tissue oxygen saturation readings from the 
thenar eminence of 381 torso trauma cases admitted to one of seven Level 1 
trauma centres.  Their aim was to determine whether tissue oxygen saturation 
readings could be utilised to predict those trauma patients who would go on to 
develop Multiple Organ Dysfunction Syndrome (MODS) or die.  The results of 
the study suggested that tissue oxygen saturation readings could identify those 
patients who would develop MODS and those who would die following their 
trauma.  Tissue oxygen saturation was as reliable as arterial base deficit and 
systolic blood pressure in identifying MODS and mortality amongst the study 
population. 
In their study of 22 critically ill patients, Lima et al (2009) also 
demonstrated that patients with a persistently low tissue oxygen saturation reading 
(<70%) on admission to the intensive care unit  following resuscitation had 
significantly worse organ failure or mortality than those with normal readings.  
However, the study failed to demonstrate any correlation between tissue oxygen 





saturation and other haemodynamic monitoring, such as heart rate, mean arterial 
pressure or central venous oxygen saturation. 
Putnam et al (2007) demonstrated that not only was tissue oxygen 
saturation as reliable as arterial base deficit and lactate in identifying hypo-
perfusion, the condition could be recognised much earlier using tissue oxygen 
saturation readings.  The results demonstrated that the lowest tissue oxygen 
saturation reading was recorded over 90 minutes earlier than the highest lactate 
value was obtained.  Early identification of hypo-perfusion allows clinicians to 
initiate appropriate interventions early. 
Convertino et al (2008) suggest that tissue oxygen saturation monitoring 
has multiple benefits over arterial base deficit and lactate in predicting hypo-
perfusion.  It is a non-invasive continuous system, which allows monitoring to be 
performed in a wide variety of settings with updated readings every few seconds.  
Blood sampling requires an invasive procedure, which may not always be 
possible, particularly in the pre-hospital setting and it provides intermittent data, 
potentially delaying the recognition of hypo-perfusion and its subsequent 
treatment.      
The main conclusions from these studies appear to be that tissue oxygen 
saturation has a place in haemodynamic monitoring as a reliable non-invasive 
system, which shows great promise, but which requires further study. 
  Crookes et al (2005) recorded tissue oxygen saturation at the thenar 
eminence in 707 healthy volunteers to establish a normal range of readings, 
although the sample population consisted of more than 60% of women; over 60% 
of the sample group were from a Hispanic background – making the results 





potentially less representative for other geographic regions.  The authors also 
recorded thenar eminence tissue oxygen saturation in conjunction with standard 
haemodynamic monitoring in 145 trauma casualties admitted to a trauma centre 
resuscitation room.  The subsequent data was presented to a panel of trauma 
surgeons, without the tissue oxygen saturation readings; the panel were asked to 
classify the severity of shock for each casualty based on the data presented.  4 
categories of shock were used: no shock, mild, moderate and severe.  Mean tissue 
oxygen saturation readings were not statistically significant between the no shock, 
mild and moderate categories and failed to differentiate between the 3 groups; 
however, tissue oxygen saturation readings did show a significant fall in the 
severe shock group.  This study was limited by the small numbers in each group; 
of 145 patients, only 19 were classified as mild shock, and 14 each in the 
moderate and severe shock groups.  The authors reported large standard 
deviations in each group as a result of the small numbers and concluded that a 
larger scale study would be required to permit the identification of any discrete 
patterns within the data. 
Creteur, Neves and Vincent (2009) describe a study to evaluate the effects 
of red blood cell transfusion on tissue oxygenation.  44 patients were included in 
the study; haemodynamic monitoring, including tissue oxygen saturation, was 
recorded pre-transfusion and 1 hour post transfusion.  All patients received one 
unit of packed red blood cells; blood gases, haemoglobin and lactate levels were 
also recorded pre- and 1 hour post transfusion.  Although haemoglobin 
concentrations increased following the transfusions, tissue oxygen saturation did 
not consistently improve as a result; however, some individuals did demonstrate 





significant changes in tissue oxygenation – interestingly, demonstrating both 
improvement and deterioration in readings.  Again, the authors conclude that 
tissue oxygen saturation monitoring may have a role in the effects of transfusion 
in the critically ill, but more studies are required. 
The majority of these studies utilised the InSpectra
™
 Tissue Oxygenation 
Monitor (Hutchinson Technology) and used the thenar eminence as the site of 
monitoring.  Soller et al (2008a) suggest that monitoring in other sites such as the 
deep muscles in the forearm may be more sensitive to changes in tissue 
oxygenation than at the thenar eminence. 
1.4. Research Aims 
 
It is this potential combination of hypoxic hypoxia and anaemic hypoxia in 
military casualties undergoing aeromedical evacuation which forms the basis for 
this study.  Anecdotal reports (Personal communication McLeod/AECC 2008) 
have suggested that several AE patients may have arrived at the receiving UK 
hospital with a haemoglobin level significantly lower than that recorded pre-
flight, despite the absence of active haemorrhage or other blood loss.  A review of 
the in-flight pulse oximetry readings for these cases failed to demonstrate a 
significant fall in arterial oxyhaemoglobin saturation; however, this is a systemic 
measurement and is not necessarily indicative of oxygenation in localised tissues 
(Schober and Schwarte, 2012).  In severely injured casualties, who may already 
be experiencing anaemic hypoxia as a result of trauma, the potential addition of 
hypoxic hypoxia may result in inadequate peripheral tissue oxygenation and end 
organ damage, associated with a less favourable outcome.  There is little evidence 





that the effects of early aeromedical evacuation in these specific casualty groups 
have been empirically considered. 
 
The aims of this research are to: 
i) Review existing clinical data for outcomes of military casualties 
undergoing AE, with particular emphasis on pre and post flight 
haemoglobin levels (Phase 1). 
ii) Determine the ability of tissue oxygen saturation monitoring to detect 
changes during a controlled model of altered perfusion (Phase 2). 
iii) Undertake an observational study to identify if changes in tissue 
oxygenation are observed in casualties undergoing AE and whether these 
changes differ dependent on haemoglobin levels (Phase 3).   





2. A RETROSPECTIVE REVIEW OF AEROMEDICAL 
EVACUATION RECORDS 
2.1. Methods  
 
Aim: The aim of phase 1 of the study was to review existing clinical data 
for the outcomes of military casualties undergoing aeromedical evacuation, with 
particular emphasis on pre- and post-flight haemoglobin levels.  This was 
achieved through a retrospective review of the aeromedical evacuation records for 
casualties returned from Afghanistan to the UK, following significant traumatic 
injury.  Specifically, the records were examined for evidence of changes in 
clinical condition and / or alterations in clinical management during the flight.  
Although it would not be possible to attribute any changes in condition or 
management to a specific cause, given the retrospective nature of the data, the aim 
was to identify the number and frequency of in-flight changes.   As the primary 
rationale for the study focused on pre-flight haemoglobin levels, a secondary aim 
was to investigate whether there were more changes in those casualties with lower 
pre-flight haemoglobin levels.  The information from this phase of the study 
would be used to inform the later observational phase. 
 
 Study protocol: The study protocol was submitted to and approved by the 
RAF Experimental Medicine Scientific Advisory Committee (RAF EMSAC) as a 
retrospective audit (EMSAC reference SP0933). 
  
 Subjects: An electronic search of the AE flight database held at the 
Aeromedical Evacuation Control Centre (AECC) at RAF Brize Norton was 
undertaken by AECC staff.  The search parameters were all CCAST flights from 
Operation HERRICK (Afghanistan) between April and November 2009.  During 





this time frame, 97 casualties were evacuated from Afghanistan, utilising critical 
care escorts.  Eight cases were subsequently excluded from the study, as the 
casualties were transferred directly to other European countries and were not 
admitted to UK hospitals, so there was no record of their subsequent management 
available for audit.  Of the 89 cases remaining, a third were randomly selected for 
review (n=29), using a random number selection programme.  However, during 
the data extraction phase, a further two cases were excluded from the audit.  
Although these 2 casualties had been brought back to a British airhead, on landing 
they had been immediately transferred to a different aircraft for onward movement 
to another country.  A total of twenty-seven cases were included in the final audit. 
 In-flight records for each of the 27 casualties were retrieved from the 
archive held by the Aeromedical Evacuation Squadron at Tactical Medical Wing, 
RAF Lyneham.  Anonymised photocopies of the records were made to permit off-
site audit; these copies were destroyed on completion of the data analysis. 
Two audit requests were made for the release of additional post-flight data 
from the Joint Theatre Trauma Registry (JTTR) held by the Academic 
Department of Military Emergency Medicine (ADMEM) at RCDM.  The data 
request was for the post-flight haemoglobin and haematocrit levels (defined as the 
first results obtained on arrival at the receiving hospital) recorded during visits by 
the military trauma co-ordinator team and the second request was for the injury 
severity score (ISS) for each casualty (see Appendix A) as calculated by the 
trauma co-ordinator from the record of the casualty’s injuries.  The ISS was 
requested, as it allows comparison of the severity of each casualty’s injuries, 





irrespective of the site or modality of their injuries and is a recognised method of 
comparing the severity of injury between poly-trauma casualties.   
 
 Audit Procedure: A standardised data collection matrix was used to 
extract relevant data from each set of AE records.  This included: 
a. Mechanism of injury 
b. Injuries sustained 
c. Injury Severity Score (ISS) and New Injury Severity Score (NISS) 
d. Blood / blood replacement therapy post injury 
e. Pre and post-flight haemoglobin and haematocrit levels 
f. Documented physiological parameters including blood pressure, 
temperature, pulse rate, respiratory rate, pulse oximetry and arterial blood 
gases (where measured) throughout the aeromedical evacuation 
g. Clinical in-flight management parameters, such as ventilator settings, and 
the rate and type of sedation agents, inotropic support or fluid replacement 
therapy given. 
The anonymised data were stored in a Microsoft
©
 Excel spreadsheet which 
permitted calculation of specific descriptive statistics. 
2.2. Results 
 
 Aeromedical evacuation of the 27 casualties from Afghanistan to the UK 
was successfully completed with no fatalities en-route.  A total of 297.75 
monitoring hours were recorded by CCAST members, with a mean transfer time 
of 11 hours per casualty (range 7-17 hours).  The difference in flight times related 
to the route taken by each aircraft, with some returning direct to the UK and some 





making re-fuelling stops in various locations en route.  All flights landed in 
Birmingham, where the casualties were off-loaded and transferred to RCDM. 
 
 Demographics:  All twenty-seven casualties were male; the mean age was 
25 years ± 6.1 (range 18-38 years).  The majority of casualties (n=26) had 
received their injuries as a result of battlefield trauma, with improvised explosive 
devices (IED) causing the majority of traumatic injuries in this group (n=23).  The 
remaining casualty had developed a non-trauma medical condition, which 
progressed rapidly, requiring urgent evacuation.  For the 26 trauma casualties, the 
mean ISS (±SD) was 31.3 ± 15.46 (range 9-75) and the mean NISS (±SD) was 
39.88 ± 18.23 (range 9-75), indicating that 25 of the casualties had sustained 
severe trauma as defined by both ISS and NISS.  With an ISS of 75, termed as 
injuries incompatible with life, 2 of the casualties were classified as ‘unexpected 
survivors’. 
  Ventilation: Twenty-six casualties had been intubated and ventilated pre-
flight and were maintained in this condition throughout their transfers.  One 
casualty was initially breathing spontaneously with supplemental oxygen via a 
face mask; however, his condition deteriorated during the flight and he required 
intubation and ventilation for stabilisation.  All casualties were ventilated using 
the LTV 1000 patient ventilator, manufactured by Pulmonetic Systems, Inc.  The 
majority of the casualties (n=18) were ventilated using the volume control mode 
on the LTV 1000 although one ventilator was reset to deliver pressure control 
mode during the transfer.  The casualty intubated en route was ventilated using 
volume control mode.  Eight casualties were ventilated using pressure control 
mode, although 2 were changed to volume control mode in-flight.   





 Details of the initial ventilator settings were extracted from the 
aeromedical evacuation records and every subsequent change to the original 
setting noted (Table 1).  Excluding changes in mode of ventilation, there were 86 
recorded alterations to ventilation settings in-flight, averaging 0.28 changes per 
hour of monitoring.     
Recorded Values Mean ± SD 
Range In-flight 
Changes Min Max 
Set tidal volume (mL) 572.5 ± 68.36 380 690   5 
Set respiratory rate (bpm)   16.1 ±   2.71   12   20 42 
Set PEEP (cm H2O)     5.9 ±   1.97     5   10   4 
Set FiO2      0.4 ±   0.16     0.3     1 35 
Table 1. Initial ventilator settings and in-flight changes 
 PEEP = Peak End Expiratory Pressure; FiO2 = Fraction of inspired oxygen 
 
  
Changes to respiratory rates were most common, with 42 changes noted, 
averaging 0.14 changes per monitored hour (Table 2).  Six casualties ended their 
flights with a higher respiratory rate setting than at the start and 11 had a lower 
rate setting; 8 casualties had unchanged respiratory rate settings and 2 casualties 
had rate changes in-flight but had returned to the original setting by the end.   
Three casualties did not have any documented changes to their ventilator settings 













Tidal volume   5 0.4 0.01 0-1 
Respiratory rate 42 1.5 0.14 0-5 
PEEP  4  0.14 0.01 0-2 
FiO2  35  1.29 0.11 0-4 
Total Changes 86  3.18 0.28 0-6 
Table 2. Mean number of changes per casualty and per monitored hour 
 
 





The second most common alteration was to FiO2 delivery, with 35 changes 
recorded.  Eight casualties ended their flights with higher FiO2 settings than at the 
start and 9 had lower settings; 7 were unchanged throughout the flight and 3 had 
been changed during the transfer but had returned to the original setting by the 
end of the flight.     
 
Figure 3. First and last FiO2 setting by casualty 
 
 
 In the majority of cases (n=25), the documented peripheral arterial oxygen 
saturation (SpO2) was between 95-100%.  One casualty had a lower range, 
between 93-96%.  The casualty who was initially breathing spontaneously showed 
a deteriorating SpO2 level and was intubated and ventilated at saturations of 89%; 
with mechanical ventilation, his SpO2 improved to 97%.  Only 1 set of records 
recorded a de-saturation event, which had been caused by a mucus plug and was 
cleared with endotracheal tube suction. 
 
 Sedation:  Five different medication types were used to maintain in-flight 


















First and Last FiO2 Setting by Casualty 
First FiO2 setting Final FiO2 Setting





medications and the remaining 5 casualties receiving a 3 medication combination.  
In total, 59 separate infusions of medication were administered between the 27 
casualties.   Propofol and fentanyl or a fentanyl derivative (alfentanil or 
remefentanil) was the most frequently used combination and was used in 17 cases 
to maintain sedation in-flight.  A midazolam and morphine combination was used 
in 4 casualties, with the remaining 6 casualties receiving alternative combinations. 
The rates of administration for each medication were titrated to individual 
need and were altered throughout the flight as required.  Thirty three infusions 
remained unchanged throughout the administration period.  In the remaining 26 
infusions, there were a total of 60 changes to the rates of administration, with a 
mean of 2.3 changes per infusion. 
 
By the end of the various flights, a review of the 59 infusions showed 15 
cases where a higher dose was being administered compared with the start of the 
flight, 11 cases where the rate had decreased and 29 cases where the rate remained 
unchanged throughout the transfer.   The breakdown of these changes is shown at 
Table 3.  In four cases, the medication rates had been altered during the flight but 
had been returned to their original rate by the end of the flight. 
Medication 
Rate Change Other Rate 
Changes
3
 Increase Decrease None 
Propofol (n=22) 5 4 10 3 
Fentanyl/Derivative (n=20) 3 3 13 1 
Morphine (n=7) 4 1 2 0 
Midazolam (n=8) 3 1 4 0 
Ketamine (n=2) 0 2 0 0 
Table 3. Comparison of pre-flight and post-flight medication administration rates 
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 Rates were changed in-flight but had been reset to the original rate by the end of the flight 





 Inotropic support:  Sixteen of the casualties required inotropic support en 
route, receiving noradrenaline infusions.  There were a total of 52 changes in the 
rates of infusion over the course of the flight, averaging 3.25 changes per casualty.  
At the end of their flight, the pre-flight infusion rates had been increased in 9 
casualties, reduced in 5 and remained unchanged in 2 casualties. 
 
 Mean arterial pressure:  Mean arterial pressure (MAP), calculated from 
the formula MAP = diastolic pressure + 1/3 (systolic pressure – diastolic 
pressure), represents the average arterial pressure perfusing the body; to maintain 
adequate perfusion of the vital organs, fluid administration and inotrope therapy is 
often titrated to maintain a minimum MAP of 60mmHg.  Individual MAP 
readings varied throughout the duration of the flights and showed wide variation 
between casualties.  These readings were normalised, to demonstrate individual 
variability throughout the flight time (Figure 4). 
Figure 4. Normalised Mean Arterial Pressure by Casualty 
 





The results of a paired t-test comparing the first and last MAP readings for 
the 27 casualties are shown at Table 4.  Although mean MAP had increased 









Mean Arterial Pressure (mmHg) 
 
 
Mean Std Err Std Dev 95% Confidence Interval 
First Hour 69.6     1.8       9.2    65.9    73.2 
Last Hour  70.9     2.1      10.7     66.7    75.1 
Difference -1.4     2.1     10.9    -5.7    2.9 
Table 4. Table comparing first and last MAP readings in 27 casualties     
 
 However, the normalised MAP chart at Figure 4 demonstrated wide 
variations in hourly readings during the flight for some individuals.  The mean 
MAP reading and the variance were calculated for each casualty for the duration 
of their flights.  As a scatter plot, this appeared to show a non-linear trend in 
readings, so a fractional polynomial regression model was fitted to predict 
variance (Figure 5) in mean MAP amongst the casualties for the duration of their 
flights.  Initially this was plotted for the entire flight duration for each casualty. 
The solid blue line shows the trend for all 27 casualties with a 95% 
confidence interval illustrated by the grey band.  As previously seen at Figure 4, 
there appeared to be wide variations in the hourly MAP during the early phases of 
the flights, so the regression analysis was repeated as previously described, using 
specific time subdivisions for closer examination of the variance.  The total flight 
time was broken down into flight hour brackets of 1-5 hours, 6-10 hours and 11-
17 hours.  During the first 5 hours of the flight (Figure 6), the variance appeared 





larger, when compared with the next 5 hours (Figure 7), when the amount of 
variance appeared to have reduced.  Four casualties in particular demonstrated 
higher variance during the first 5 hours of monitoring. 
 




Figure 6. Mean MAP predicted variance by casualty for flight hours 1 to 5 
 






Figure 7. Mean MAP predicted variance by casualty for flight hours 6 to 10 
 
 
Haemoglobin levels: A review of the pre-flight haemoglobin levels 
revealed that 14 casualties had a haemoglobin level below 10g/dL prior to the 
start of their transfers (range 6.5 – 9.9g/dL); pre-flight blood had been 
administered to 12 of these individuals (information for the remaining 2 casualties 
was not provided).  A total of 208 units of blood (range 1-30; mean 17.3 
units/casualty) and 206 units of fresh frozen plasma (FFP) (range 1-30; mean 17.1 
units/casualty) had been transfused into this group in the time between injury and 
aeromedical evacuation.  Nine of these casualties received further blood products 
in-flight: 13 units of blood (mean 0.9 units/casualty) and 5 of FFP (mean 0.3 
units/casualty). 
 The remaining 13 casualties had haemoglobin levels above 10g/dL pre-
flight (range 10.1-14.3g/dL).  Eight sets of records indicated that the casualties 
had received blood transfusions in the time between injury and transfer, receiving 





a total of 166 units of blood (range 0-31; mean 20.75 units/casualty) and 148 units 
of FFP (range 0-31; mean 18.5 units/casualty).  Records of pre-flight 
administration for the remaining 5 casualties were not provided.  Three of the 13 
casualties received further blood products in-flight: 5 units of blood (mean 0.4 
units/casualty) and 3 units of FFP (mean 0.2 units/casualty). 
 Of the 14 casualties with a pre-flight haemoglobin below 10g/dL, twelve 
had a higher post-flight haemoglobin and nine of these had a post-flight 
haemoglobin above 10g/dL.  In the group with a pre-flight haemoglobin level 
above 10g/dL, seven had a higher post-flight haemoglobin level; five had a lower 
post-flight level (2 of which fell below 10g/dL) and 1 casualty’s haemoglobin 
remained unchanged.  Figure 8 depicts the pre and post-flight haemoglobin levels 
for each casualty.   
 
Figure 8. Pre- and post-flight haemoglobin levels by casualty 
  
 
Table 5 demonstrates the results of a paired t-test comparing pre and post-






















Pre and Post Flight Haemoglobin Levels 
Pre-flight Hb Post-flight Hb





haemoglobin result was almost 1g/dL higher than the mean pre-flight result and 









 Mean Std Err Std Dev 95% Confidence Interval 
Pre Flight 10.4     0.3           1.8   9.7      11.1 
 
Post Flight  11.3*     0.4            1.9     10.5      12.0 
Difference -0.9         0.4       2.0     -1.7       -0.1 
Table 5. The results of a paired t-test comparing pre and post-flight haemoglobin levels in 27 
casualties 
* indicates p<0.05 compared to pre-flight value 
 
 
The total number of changes in clinical management was subdivided to 
compare whether casualties with a lower pre-flight haemoglobin level (<10g/dL) 
were subject to more changes in management during aeromedical evacuation 
(Table 6) than were casualties with a higher pre-flight haemoglobin level 
(>10g/dL).  The number of changes in clinical management in-flight was similar, 
with the exception of sedation rate changes.  More changes were seen within the 
higher pre-flight haemoglobin group, but 19 of the 44 changes were seen in just 2 
casualties, both of whom had suffered head injuries and required close control of 
systolic blood pressure to prevent raised intra-cranial pressure.  Administration 
rates for sedation medication were adjusted frequently in these two casualties to 
assist with maintaining a stable systolic blood pressure.  Excluding the changes in 
sedation rates for these two individuals brought the number of changes seen in the 
higher pre-flight haemoglobin group down to 25, which was still slightly more 
than in the other group.  
 
 










Sedation Rate Changes (n=60) 44 16 
Inotrope Rate Changes (n=52) 24 28 
FiO2 Changes (n=35) 18 17 
Respiratory Rate Changes (n=42) 25 17 
Total Ventilation Changes (n=86) 47 39 
Table 6. Number of clinical management changes by haemoglobin level 
 
 The earlier comparison of pre- and post-flight infusion rate settings were 
also subdivided by haemoglobin level, to compare whether there were more 
changes in the group with a lower haemoglobin level during aeromedical 
evacuation.  The breakdown of this comparison is shown at Table 7 and 






Sedation Infusion (n=59) 
Increase 9 6 
Decrease  6 5 
No Change 12 (2)
4
 17 (2) 
Inotrope Infusion (n=16) 
Increase 2 3 
Decrease 5 4 
No Change 1 1 
 
Respiratory Rate (n=27) 
Increase 3 3 
Decrease 7 4 
No Change 2 (1) 6 (1) 
Table 7. Post-flight changes in pre-flight infusion rate settings by haemoglobin level 
 
 Table 8 demonstrates the total number of sedation infusions where the pre-
flight setting had been altered by the end of the flight compared with the number 
of sedation infusions which were unchanged throughout the flight, further 
subdivided into 2 groups by haemoglobin level.  Again, the numbers for each 
group were very similar and a Pearson’s chi-squared test demonstrated no 
statistical significance (p=0.244) between the 2 groups.   
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Bracketed figures depicts where rates were changed in-flight but had been reset to the original 
rate by the end of the flight  









Rate Changed 15 11 
Rate Unchanged 14 19 
Table 8. A comparison of final sedation infusion rate changes by haemoglobin level 
 
 Eleven of the casualties had been transported with a cabin altitude 
restriction; in these cases, the pressurisation of the aircraft cabin was maintained 
at an altitude between 3,000 to 5,000ft, instead of the usual range of between 
6,000 and 8,000ft.  These restrictions were prompted by the casualties’ injuries 
and clinical condition, and were made to minimise the effects of pressure change 
caused by ascent to altitude, which could potentially exacerbate the original 
injuries sustained.  For example, penetrating head or eye injuries where air had 
entered previously closed spaces; expansion of the air with increasing altitude 
would potentially increase the damage caused to the brain or eye.    
2.3. Discussion 
 
 Random selection of the cases included in the retrospective audit reduced 
the risk of any selection bias; although the 97 casualties injured during the 
specified time frame would be from a relatively homogenous group – as serving 
members of the military, the population at risk is aged between 18 and 55 years, 
pre-dominantly male and in good health prior to sustaining injury.  In their study, 
Allcock et al (2011) undertook a retrospective review of the records for all UK 
casualties, injured in Afghanistan as a result of trauma, who received a massive 
blood transfusion.  Some of the casualties from the current study would have been 
amongst the 59 cases included in Allcock’s review.  All casualties were male, and 
the authors reported the median age was 23.5 years (range 18.1 - 42.3 years), 





demonstrating that serving military personnel belong to a relatively homogenous 
group.  
 This retrospective audit of aeromedical evacuation records demonstrated a 
number of in-flight changes in clinical condition and / or clinical management for 
the 27 cases reviewed.  In the main, the casualties had received severe traumatic 
injuries which required initial damage control surgery and / or massive 
transfusions of blood and blood products, necessitating early aeromedical 
evacuation to the UK for further surgical and medical management.  The 
hypothesis under test in this phase of the study was that casualties with lower pre-
flight haemoglobin levels, defined as less than 10g/dL, would experience more in-
flight changes in clinical condition and / or clinical management than casualties 
with higher pre-flight haemoglobin levels, above 10g/dL.  However, data analysis 
revealed very little difference between the two groups.  It was observed that most 
of the changes in clinical management were seen in the casualties with a higher 
pre-flight haemoglobin level; however, some of the in-flight management changes 
seen in this group were due to an improvement in the casualty’s condition, leading 
to a reduction in their treatment requirements.  A further analysis of the 
management changes was undertaken with the aim of dividing the changes into 
positive and negative changes (i.e. changes in response to an improvement in the 
casualty’s condition (positive) compared with changes in response to any 
deterioration in the casualty’s condition (negative)).  The goal was to compare the 
number of positive and negative changes for both haemoglobin groups.  However, 
it quickly became evident that this aim was too simplistic, as some seemingly 
positive changes could actually be negative changes.  An example of this was seen 





in the changes made to a casualty’s sedation treatment; the charts showed the 
hourly rate was being reduced, which could be seen as a positive change, with the 
casualty requiring less sedation to maintain a stable condition.  However, in the 
written records, it was documented that the sedation rates had been altered to 
maintain a narrow range of systolic blood pressure to prevent raised intra-cranial 
pressure in a head injured patient, so actually demonstrating a negative change in 
clinical management.  Likewise, reductions in ventilation requirements can 
initially be seen as a positive change, unless the changes are made in an attempt to 
lower a rising end tidal carbon dioxide level, in a casualty whose condition is 
deteriorating. 
In-flight physiological monitoring of the casualties was undertaken, 
capturing a variety of data including blood pressure, heart rate and temperature.  
The aim was to examine the hourly measurements for each casualty to identify 
changes in condition during the AE.  However, accurate data extraction of these 
variables from the casualties’ records was difficult to achieve, as they were 
documented in graphic format, more designed to show trends across time.  Mean 
arterial pressure was recorded in numeric format, making data extraction more 
precise.  For this reason, analysis of the physiological monitoring recorded was 
restricted to mean arterial pressure.  A t-test comparison of the first and last MAP 
readings for the 27 casualties failed to demonstrate any significant changes, which 
was confirmed by an ANOVA comparing mean MAP readings at the first, fifth 
and last hour of the individual flights.  However, there were obvious fluctuations 
in the hourly measurements for several individual casualties.  During analysis of 
the variance in MAP between individuals, 4 casualties were identified as having a 





higher variance than the remaining 23 casualties.  As previously discussed, it is 
difficult to attribute this variation to one particular cause; although all 4 had been 
injured as a result of IED blasts, they had suffered different types of injuries, 
affecting different body regions and accordingly had received different clinical 
management.  Interestingly, the MAP variance analysis actually demonstrated 
greater variance in the first five hours of in-flight monitoring, compared with later 
stages of the flights.  During this phase, the casualties have been moved from the 
Intensive Care Unit at the Field Hospital via battlefield ambulance to the back of 
the aircraft and then exposed to pressure and environment changes as the aircraft 
begins the journey back to the UK.  These events are likely to have an effect on 
the casualties’ physiological condition initially.  Once the casualties’ conditions 
had stabilised and the aircraft was at a cruising altitude, fewer fluctuations in 
mean arterial pressure were seen in the later phases of the aeromedical evacuation, 
when fewer interventions were initiated.  The aeromedical evacuation records end 
when the casualties are off-loaded at Birmingham, but it would be interesting to 
examine the MAP variance in the first few hours after arrival at the receiving 
hospital, after the casualty has been exposed to the pressure and environmental 
changes during the aircraft’s descent followed by a road transfer by ambulance to 
hospital.   
    
 In their 2006 study, Barnes et al (2008) undertook continuous monitoring 
of 22 ventilated casualties during aeromedical evacuation between Iraq and 
Germany.  The casualties in the 2006 study and the current study had a similar 
mean age (27 years compared with 25 years) and similar ISS (31.75 compared 





with 31.3). The authors of the 2006 study identified that the most common change 
made to ventilator settings was to FiO2 delivery, averaging 0.27 changes per 
monitored hour; within the current study, FiO2 delivery was the second most 
common change, averaging 0.11 changes per hour.  Set respiratory rate was the 
second most common change in the 2006 study, averaging 0.22 changes per hour 
which compares with 0.14 changes per hour in the current study.  In total, there 
were fewer changes to ventilator settings in the current study compared with the 
2006 study, although neither study demonstrated large numbers of changes in 
ventilation.  However, the 2006 study recorded continuous data from the 
ventilators, meaning all changes were recorded; in the current study, it is possible 
that any changes occurring between the hourly recordings of data could be missed 
and so omitted from the overall analysis.  Only 3 episodes of de-saturation 
(defined as SpO2 less than 90%) were recorded during the continuous monitoring 
in the 2006 study. These events ranged from 35 seconds to 4 minutes 40 seconds 
in duration and all resolved without intervention.  In the current study, which 
analysed hourly monitoring records, only one de-saturation event was described, 
which required clinical intervention to resolve the situation. 
 
 Limitations: The retrospective nature of the current study made analysis of 
the data challenging.  Any changes in physiological condition which occurred 
between the hourly recordings were potentially lost from the analysis, unless 
documented in the written records.  The reasons for changes in clinical 
management were, at times, unclear and not always documented in the 
aeromedical evacuation records, so although, for example, there were more 





changes in sedation rates in the higher pre-flight haemoglobin group, this was not 
necessarily an objective comparison for the reasons discussed earlier.  Likewise, 
the different CCAST personnel involved in each flight may have had an impact in 
the number or type of changes in clinical management; more experienced 
personnel might have been more confident in making in-flight changes in 
response to improvements in the casualty’s condition than less experienced 
personnel, who might be more content to maintain pre-flight settings in the 
absence of any deterioration of the casualty’s condition during aeromedical 
evacuation. 
 
 Conclusion: In this retrospective audit of aeromedical evacuation records, 
in-flight changes in clinical condition and medical management were seen; 
however, haemoglobin status did not appear to be a predictor for this, as more 
changes were seen in the group with higher pre-flight haemoglobin levels.  This 
would suggest that a low haemoglobin level should not in itself delay aeromedical 
evacuation; however, the physiological monitoring undertaken during these flights 
is predominantly measuring systemic markers and provides little information on a 
regional level.  










The Defence Medical Services provide an aeromedical evacuation service 
to repatriate military personnel who become ill or are injured whilst serving 
abroad.  Critically ill patients who require high dependency or intensive care 
management in-flight are escorted by a critical care air support team (CCAST) 
carrying appropriate support equipment. 
One such item of CCAST support equipment is the LTV 1000 patient 
ventilator, manufactured by Pulmonetic Systems, Inc, Minneapolis, MN, USA.  
During the retrospective review of aeromedical evacuation records carried out 
during phase 1 of this study, a comment was found written in one of these sets of 
records suggested that the LTV ventilator did not appear to be delivering the pre-
set tidal volumes whilst in use at altitude.  As a result of this comment and some 
anecdotal reports from CCAST clinicians regarding potential physiological 
indications of hyperventilation at altitude, it was decided to undertake an 





Aim: The aim of the study was to examine the performance of the LTV 
1000 patient ventilator both on the ground and during an ascent in a hypobaric 
chamber to the maximum expected cabin altitude of 8,000 feet (2438 metres), 
which is equal to an environmental pressure of 565mmHg.  This would allow 
                                                 
5
 Ventilator study undertaken in conjunction with Wg Cdr N Green, Consultant Advisor in 
Aviation Medicine and Gp Capt M Peterson, Consultant Anaesthetist.  





comparison of operational performance at ground level and at simulated altitude 
to ensure consistency.     
 
Study Protocol: As the study aim was to examine the performance of the 
ventilator, using a lung simulator only, and did not include measurements made 
on human volunteers, Ministry of Defence Research Ethics Committee 
(MoDREC) approval was not sought. 
 
Mechanical Ventilation:  During phase 1 of the present study, it was 
identified that mechanical ventilation of the casualties was undertaken utilising 
both pressure controlled and volume controlled ventilation.  In volume control 
mode, the tidal volume of each breath is programmed by the anaesthetist along 
with a respiratory rate.  The inspiratory flow remains constant but airway pressure 
increases throughout the breath to enable volume delivery.  As the volume of each 
breath is pre-determined, the casualty will receive a set tidal volume, but airway 
pressures are variable, depending on the compliance and resistance of the 
respiratory system.  In a casualty with reduced compliance or higher resistance, 
there is an increased risk of ventilator induced lung injury as a result of the higher 
airway pressures required to deliver the set tidal volume (Campbell and Davis, 
2002). In pressure control mode, the anaesthetist sets an inspiratory airway 
pressure and respiratory rate but the volume delivered in each breath will vary 
according to respiratory system compliance and resistance.  Airway pressure 
remains constant during the breath, with a decelerating inspiratory flow pattern.  
(MacNaughton, 2008; Bersten, 2014).  The choice of volume or pressure 





controlled mode will depend on many factors, including the underlying reason for 
mechanical ventilation.       
 Experimental Procedure: Three LTV 1000 patient ventilators were 
selected at random from the CCAST inventory held at the RAF Centre of 
Aviation Medicine (RAF CAM) (inventory numbers 2291, 2283 and 1458).  All 
devices had been maintained in accordance with manufacturer’s instructions.  
Standard pre-use checks were completed prior to any testing; all devices passed 
these checks.  All ventilators were connected to AC mains power throughout 
testing and 100% oxygen was supplied to the ventilators at 50Lb.in
-2
 from a 
bottled source located within the hypobaric chamber.  Each ventilator was fitted 
with a standard ‘Y’ patient ventilation circuit, with a positive end expiratory 
pressure (PEEP) valve at the end of the exhalation side and a lung simulator (IMT 
Medical, Switzerland) at the inhalation side – replicating the ventilator assembly 
used in patient care. 
 
 Figure 9. Schematic of the LTV1000 ventilator test design 
 
Fleisch flow meters and piezometer pressure taps were fitted at the 
ventilator outlet port and at the lung simulator inlet port to measure flow and 





pressure.  The Fleisch flow meters were calibrated for flow using a calibrated 
rotameter and for pressure using a calibrated 3L syringe.  Calibrations were only 
performed at ground level as the Fleisch flow meter is unaffected by changes in 
altitude, due to the laminar flow of air within the flow meter.  The differential 
pressure transducers, connected via piezometer pressure taps, were calibrated 
using a calibrated manometer.  
Data measured at the ventilator outlet port and at the lung simulator inlet 
port (Table 9) were captured by a digital data acquisition system at 400Hz 
(LabChart
®
 7, AD Instruments Ltd, Oxford) and later exported to a Microsoft
©
 
Office Excel file.  All volumes were corrected to ambient temperature and 
pressure dry (ATPD).  The lung simulator was set at a compliance of 30ml/bar 




 to simulate a normal adult lung. 
Variable Measurement Technique 
Ventilator outlet flow 
 
Fleisch flow meter size 2 (Linton Instruments 
Ltd) 
Ventilator outlet pressure 
 
Differential pressure transducer model LCVR 
(Celesco Inc.) 
Lung inlet flow 
 
Fleisch flow meter size 2 (Linton Instruments 
Ltd) 
Lung inlet pressure 
 
Differential pressure transducer model LCVR 
(Celesco Inc.) 
Hypobaric chamber differential pressure 
Differential pressure transducer model LCVR 
(Celesco Inc.) 
Chamber temperature and humidity Digital thermometer 
Table 9. Measured variables during LTV 1000 patient ventilator assessment 
 
The ventilators were placed in the hypobaric chamber; once readings had 
been recorded at ground level, the pressure in the chamber was reduced to a 
pressure altitude of 8,000 feet.  Two different ascent profiles were used during the 
assessment, one at 500 feet per minute (to simulate a similar climb rate to that of a 
standard aeromedical evacuation flight) and one at 2,000 feet per minute.  During 





the slower ascent profile, readings were measured continuously; at the faster 
ascent rate, readings were recorded on the ground and at 8,000 feet only.  Once at 
altitude, readings were recorded for a 2 minute period before increase in 
hypobaric chamber pressure to ground level at 4,000 feet per minute. 
 Each ventilator was tested in both volume control mode and pressure control 
mode.  In volume control mode, the ventilators were set to deliver a tidal volume 
of 600ml at a rate of 12 breaths per minute, both with and without PEEP (at 
5cmH2O) on air.  In pressure control mode, the pressure was set to 20cmH2O.  As 
an additional test, 1 ventilator was set to deliver 600ml in volume control mode 
with and without PEEP (at 5cmH2O) on 100% oxygen.  Each ventilator was tested 
once for each experimental condition described.  The order for the experimental 

















0.21 0 0.6 Volume control 
8000 2000 0.21 0 0.6 Volume control 
0  
2283 
0.21 0 0.6 Volume control 
8000 2000 0.21 0 0.6 Volume control 
0  
1458 
0.21 0 0.6 Volume control 
8000 2000 0.21 0 0.6 Volume control 
0  
2291 
0.21 5 0.6 Volume control 
8000 2000 0.21 5 0.6 Volume control 
0  
2283 
0.21 5 0.6 Volume control 
8000 2000 0.21 5 0.6 Volume control 
0  
1458 
0.21 5 0.6 Volume control 
8000 2000 0.21 5 0.6 Volume control 
0  
2291 
0.21 5 0 Pressure control (20cmH2O) 
8000 2000 0.21 5 0 Pressure control (20cmH2O) 
0  
2283 
0.21 5 0 Pressure control (20cmH2O) 
8000 2000 0.21 5 0 Pressure control (20cmH2O) 
0  
1458 
0.21 5 0 Pressure control (20cmH2O) 
8000 2000 0.21 5 0 Pressure control (20cmH2O) 
0  
1458 
1.0 5 0.6 Volume control 
8000 500 1.0 5 0.6 Volume control 
0  
1458 
1.0 0 0.6 Volume control 
8000 500 1.0 0 0.6 Volume control 
Table 10. Order of experimental conditions used during LTV ventilator assessment.  Three 
ventilators were used, with each ventilator tested once under the conditions described 
FiO2 = Fraction of inspired oxygen 







 Data obtained from the flow meters and pressure taps fitted at the 
ventilator outlet port and at the lung simulator inlet port were in good agreement. 
 In volume control mode on air, without PEEP, the ventilators delivered a 
larger tidal volume at 8,000ft compared with ground level. At the ventilator outlet 
port, the mean tidal volume increase was 17.5% (SD ±0.8%), as demonstrated in 
Figure 10.  When PEEP of 5cmH2O was added to volume control mode on air, a 
similar response was seen, with the mean tidal volume recorded at the ventilator 
outlet port 15.9% (SD ±1.8%) greater at 8,000ft than at ground level.  Individual 
ventilator results in volume control mode are shown at Table 11, demonstrating 










Delta TV  
(l) 
2291 
0 0 0.585   
8000 0 0.692 0.107 
2283 
0 0 0.613   
8000 0 0.721 0.109 
1458 
0 0 0.593   
8000 0 0.692 0.100 
2291 
0 5 0.585   
8000 5 0.689 0.104 
2283 
0 5 0.621   
8000 5 0.717 0.096 
1458 
0 5 0.593   
8000 5 0.678 0.085 
Table 11. Delivered tidal volume (TV) measured at the ventilator outlet port at both ground 
level and 8,000ft simulated altitude in 3 ventilators.  Ventilators in volume control mode, tidal 
volume 0.6L with either PEEP 0 or PEEP 5cmH20 
PEEP = Positive End Expiratory Pressure 
  
 
 Peak inspiratory pressure (PIP) also increased at altitude in volume control 
mode; at the lung simulator inlet port, mean PIP increased by 17.2% (SD ±9.7%) 





at 8,000ft compared with ground level.  This increase in PIP was exacerbated with 
the addition of PEEP; with 5cmH2O added to the ventilator settings, mean PIP at 
the lung simulator inlet port was 69% (SD ±48.5%) greater at altitude compared 
with ground level – a much greater increase than without PEEP.  Individual 
results for each of the three ventilators are shown at Table 12, demonstrating an 















0 0 16.6   
8000 0 17.8 1.2 
2283 
0 0 17.0   
8000 0 21.5 4.6 
1458 
0 0 16.5   
8000 0 19.4 2.9 
2291 
0 5 19.0   
8000 5 27.6 8.6 
2283 
0 5 16.7   
8000 5 37.6 20.9 
1458 
0 5 25.0   
8000 5 34.2 9.2 
Table 12. Peak inspiratory pressure (PIP) measured at the lung simulator inlet port at both 
ground level and 8,000ft simulated altitude in 3 ventilators.  Ventilators in volume control 
mode on air, tidal volume 0.6L with either PEEP 0 or PEEP 5cmH20 
PEEP = Positive End Expiratory Pressure 
 
 As shown in Table 13 and at Figure 10, the large increases in tidal volume 
were not seen when the ventilators were set in pressure control mode and mean 
PIP was only minimally increased at altitude (3% (SD ±7.4%)) compared with 
ground level.  Three ventilators were used and each was tested once using the 
described experimental design. 


























0 20 0.587 23.4     
8000 20 0.612 25.1 0.025 1.7 
2283 
0 20 0.636 27.8     
8000 20 0.622 26.3 -0.014 -1.5 
1458 
0 20 0.614 22.8     
8000 20 0.635 24.5 0.022 1.7 
Table 13.  Tidal volume (TV) measured at the ventilator outlet port and peak inspiratory 
pressure (PIP) measured at the lung simulator inlet port at both ground level and 8,000ft 
simulated altitude in 3 ventilators.  Ventilators in pressure control mode (20cmH2O) on air, 
with PEEP 5cmH20 
 
 
Figure 10. Mean increase in tidal volume (TV) at 8,000ft compared with ground level, 
measured at the ventilator outlet port in 3 ventilators 
Fraction of inspired oxygen = 0.21; Error bars show ±1 standard deviation 
 
 
  At the slower ascent rate (500 feet per minute), readings of tidal volume 
and peak inspiratory pressure from 1 ventilator were monitored continuously and 
recorded at 1000ft intervals as the hypobaric chamber climbed from ground level 
to a simulated altitude of 8,000ft.  Figure 11 depicts the increase in delivered tidal 
volume and PIP as measured at the ventilator outlet port for one ventilator 
(number 1458) in volume control mode, on air, without PEEP during the ascent to 
8,000ft.  As previously seen, the addition of PEEP caused a greater increase in 





PIP, suggesting that the percentage increase in PIP shown in Figure 11 would 
have been greater had PEEP been added to the ventilator set up.  
 
Figure 11. Increases in delivered tidal volume and peak inspiratory pressure at the ventilator 
outlet port during a climb to 8,000ft simulated altitude in a hypobaric chamber; data from 1 
ventilator. Ventilator in volume control mode, tidal volume 0.6L, PEEP 0 
 
 
 Throughout the ventilator assessment, there was disparity between the set 
tidal volume, the tidal volume which the LTV 1000 displayed as being delivered, 
and the actual tidal volume recorded at the ventilator outlet port.  Figure 12 
depicts the mean difference in the reported tidal volume shown in the display 
screen on the LTV 1000 and the delivered tidal volume recorded at the ventilator 
outlet port.  On the ground and at altitude, the actual delivered tidal volume was 
greater than that reported on the LTV display screen, with the difference ranging 
from approximately 5% to 25%, according to the ventilator mode and settings 
used.  On the ground, the difference between delivered tidal volume and displayed 
tidal volume was at the maximum permitted design tolerance for the ventilator 
(Pulmonetic Systems 2005); at altitude, the differences were beyond these 





permitted tolerances.  The addition of PEEP further increased the differences in 
delivered tidal volume and displayed tidal volume.    
 
Figure 12. Mean difference in tidal volume (TV) measured at the ventilator outlet port 
compared with tidal volume displayed on the LTV1000 screen in 3 ventilators; each 
ventilator tested once. 
Fraction of inspired oxygen = 0.21; Error bars show ±1 standard deviation 
 
 Data were collected from three ventilators; each ventilator was tested once 
under each experimental design described.  Guidance from a statistician suggested 
that the sample size was too small to undertake any meaningful/valid statistical 
analysis beyond the descriptive analysis described above (Personal 
communication McLeod/Kiran May 2015). 
 
3.3. Discussion 
The data obtained during the experimental phases were consistent between 
the three ventilators tested.  At simulated altitude, in volume control mode, the 
ventilators delivered larger tidal volumes than had been set and larger tidal 
volumes than were reported on the LTV 1000 screen.  At 8,000ft, the mean 
difference in volume was approximately 20% which is a larger difference than the 





5%-12% difference identified by Rodriquez et al (2009) in a similar study, 
examining the performance of the LTV 1000 and the Impact Eagle 754 (Impact 
Instrumentation Inc, West Caldwell, NJ) at various simulated altitudes.  Only one 
LTV 1000 ventilator was tested in the Rodriquez study though, which was 
identified as a limitation of their study, as it only provided one set of data for 
analysis. 
In volume control mode, peak inspiratory pressure also increased 
significantly at altitude, compared with ground level readings, and was further 
increased by the addition of positive end expiratory pressure.  Measurements of 
PIP were not tested in the Rodriquez et al (2009) study, so no data are available 
for comparison with the current study.  These larger tidal volumes and higher PIP 
were seen in all three ventilators tested and did not seem to be affected by 
alterations in the oxygen concentration delivered, a finding which was also 
reported by Rodriquez et al (2009). 
The patient ventilation circuit contains a fixed orifice transducer device 
(Pulmonetic Systems, 2005) which measures pressure drop to gauge the flow and 
volume of gas delivery, which is then reported on the ventilator screen.  Flow 
through the orifice is turbulent; therefore, as the air density falls with increased 
altitude, the pressure drop is reduced.  This leads to the underestimation of actual 
tidal volume, and hence the delivery of a larger than necessary volume by the 
control circuit, in both volume and pressure control modes.  Flynn and Singh 
(2008) suggest that this turbulent air flow through the ventilator’s flow valve also 
explains the larger tidal volumes delivered in volume control mode.  As altitude 
increases, the air density decreases, but the gas expands; to maintain the pressure 





drop, this results in a larger volume being delivered at altitude.  In pressure 
control mode, ventilation is not dependant on this flow measurement, but on 
differential pressure, which explains why performance at altitude is similar to that 
seen at ground level in this mode.  The differential pressure transducer 
compensates for changes in ambient pressure (Pulmonetic System, 2005). 
Comparing the findings of the current study with other similar studies 
revealed that only 1 other study examined the LTV 1000 ventilator (Rodriquez et 
al, 2009) at altitude; the performance of different ventilators were examined in 
other studies (Flynn and Singh, 2008; Roeggla et al, 1995; Thomas and 
Brimacombe, 1994) which demonstrated that other devices failed to operate as 
effectively at altitude compared with ground level, delivering larger tidal volumes 
and reduced respiratory rates.  Each study used a different set of test parameters – 
different altitudes and different lung models, making direct comparison with the 
present study challenging.  Tourtier et al (2010) recognise the problematic nature 
of comparing these studies and suggest that an international standard be 
developed to allow benchmarking of ventilator performance at altitude.  
The findings from both the present study and from others may have 
implications for the care of critically injured ventilated casualties during 
aeromedical evacuation.  Awareness of the potential delivery of larger than 
intended tidal volumes or higher PIP is essential to prevent further harm to these 
vulnerable personnel.  Large tidal volumes and high peak inspiratory pressures in 
ventilated patients could be harmful (Roeggla et al, 1995), particularly in those 
casualties with existing lung injuries, in whom large tidal volumes will increase 
their risk of developing ventilator induced lung injury (VILI) (Bersten, 2014).  In 





phase 1 of this present study, 23 of the casualties had been exposed to blast from 
an improvised explosive device, potentially resulting in some degree of lung 
damage, which could be exacerbated in the presence of large tidal volumes or 
high inspiratory pressures during ventilation.  High PIP could potentially cause 
further barotrauma to blast injured lungs; Reade and Thomas, (2014) suggest 
reducing PIP when managing blast injured casualties to prevent further damage 
and Smith (2011) suggests the use of low tidal volumes and the use of pressure 
controlled ventilation in this casualty group.  Findings from the present study 
suggest that the current CCAST ventilator may deliver larger tidal volumes or 
higher PIP at altitude; these findings should be considered when utilising the 
ventilator during aeromedical evacuation, particularly when volume control mode 
is selected. 
Barnes et al (2008) suggest that military trauma casualties are also at risk 
of developing Acute Respiratory Distress Syndrome (ARDS) due to the nature of 
the injures experienced.   Lumb (2000) and Vicente et al (2015) suggest the use of 
smaller tidal volumes and lower airway pressures in the management of ARDS to 
reduce the risk of volutrauma or over-distension of the alveoli.  Increased 
intrathoracic pressure resulting from elevated PIP may also have haemodynamic 
consequences for the casualty, through reduced pre-load (reduced venous return) 
(Cockings and Yap, 2008), ultimately reducing cardiac output.  Additionally, 
large tidal volumes could lead to hypocapnia resulting from hyperventilation.  
This can lead to cerebral vasoconstriction, a left shift of the oxy-haemoglobin 
dissociation curve and cardiac arrhythmias (Rodriquez et al, 2009).  In a casualty 
group who may have already experienced significant haemorrhage, blast lung, 





head injury or traumatic amputations, avoidance of these additional complications 
is essential.  The development of cerebral vasoconstriction in a head injured 
ventilated casualty, for example, as a result of hyperventilation from larger than 
intended tidal volumes during evacuation may lead to a much worse prognosis 
than expected.      
 
 Limitations:  The ventilators were only tested using a lung simulator set to 
represent the compliance of a normal adult lung; and altered lung compliance 
profiles were not assessed.  Testing the ventilators at a simulated altitude in the 
hypobaric chamber permitted exposure to reduced barometric pressure but did not 
include any of the other factors potentially experienced during flight, such as 
noise or vibration.  Only three ventilators were used during the testing, with each 
ventilator tested once under the experimental conditions described.  As this design 
produced only 3 data sets, statistical analysis was not possible; however, the 
results obtained were borne out by results of earlier studies and have contributed 
to the developing body of knowledge regarding the performance of ventilators at 
altitude.  Although the recommendations made in the next section are not based 
on statistical analysis, they are echoed by other researchers in this field of inquiry.  
 
 Conclusion: At a simulated altitude of 8,000ft, in volume control mode, 
the LTV 1000 ventilator delivered higher tidal volumes than had been set, but 
under-reported the actual tidal volumes delivered.  Peak inspiratory pressures 
were significantly increased at this altitude compared with ground level values 
and the addition of PEEP further increased the PIP at 8,000ft.  In pressure control 





mode, tidal volumes and PIP virtually matched ground level values, although 
delivered tidal volumes were under-reported on the ventilator screen.   Although 
these findings result from a small scale study involving only 3 LTV 1000 
ventilators, from which meaningful statistical analysis could not be undertaken, 
they still suggest that the ventilator does not compensate for the changes in 
barometric pressure experienced during flight and may therefore not performed as 
intended.  As a result of these findings, CCAST personnel should consider 
reducing set in-flight tidal volumes if the LTV 1000 is used at altitude in volume 
control mode.  To avoid the high PIP seen, CCAST casualties could be ventilated 
using pressure control mode during aeromedical evacuation where practical.  In 
the longer term, any future replacement for the LTV 1000 ventilator currently 
used by CCAST should auto-compensate for the barometric changes experienced 
during flight.





4. HYPOBARIC ASSESSMENT OF THE ABBOTT i-STAT 




Blood gas analysis is an essential component of critical care provision 
(McGuire, 2006a).  During evacuation by air, clinical examination becomes more 
difficult due to environmental factors such as altered light levels and increased 
noise, which makes some techniques such as auscultation impossible.  As a result, 
accurate blood gas analysis becomes even more critical to ensure effective 
ventilation is being delivered.  For this reason, the critical care air support team is 
equipped with a portable hand held analyser, the i-Stat 1, manufactured by Abbott 
Laboratories Ltd.  As CCAST personnel rely on the accuracy of the results from 
the i-Stat analyser, the performance of the i-Stat was assessed at altitude.     
 
Aim: The aim of the study was to examine the performance of the i-Stat 1 
blood gas analyser both on the ground and at the maximum expected cabin 
altitude of 8,000 feet (2438 metres).  This would allow comparison of operational 
performance at ground level and at simulated altitude. 
 
 Study Protocol: As the study aim was to examine the performance of the 
blood gas analyser, using only test control solutions, and did not include 
measurements made on human volunteers, MoDREC approval was not sought.  
 
 Experimental Procedure: Four i-Stat analysers were used during the 
study; one from the RAF CAM inventory and 3 provided by Abbott Laboratories 
(Table 14).  EG7+ cartridges (Lot P10317 and N10354) were selected for the 





testing to provide a wide range of commonly used biochemical and 
haematological investigations, including arterial oxygen and carbon dioxide, pH 
and electrolytes.  It is also the cartridge most commonly used by CCAST 
personnel. 





Table 14. i-Stat handset serial numbers 
 
To confirm that the i-Stat cartridges perform within specified limits, 
reference assay solutions are available.  Performance of the i-Stat devices was 
assessed using four different assay solutions, to test the high and low ranges: i-
Stat Control 1 (Lot B09349), i-Stat Control 3 (Lot B09344), Haematocrit Control 
1 (Lot B09322) and Haematocrit Control 3 (Lot B09323).  The i-Stat Control 1 
and 3 solutions are specifically prepared with known concentrations of 
electrolytes (sodium, potassium and chloride), arterial oxygen and carbon dioxide, 
glucose, lactate and creatinine, to act as quality assurance tools.  i-Stat Control 1 
solution has low concentrations of these assays and i-Stat Control 3 solution has 
high concentrations.  Likewise, the Haematocrit Control solutions are designed as 
quality assurance tools to test the performance of the monitor and cartridges; 
Haematocrit Control 1 solution has a known low haematocrit (HCT) concentration 
and Haematocrit Control 3 solution has a known high HCT concentration.  The 
HCT control solutions are only designed to test HCT levels detected by the 
cartridges and all other results obtained from the cartridge when using the HCT 
control solutions should be discounted (Abbott, 2015 p14-12).      





The i-Stat units were tested at ground level (761mmHg) and at the pressure 
altitude equivalent of 8,000 feet (565mmHg) in a hypobaric chamber at RAF 
CAM.  For each device, ground level testing was completed prior to testing at 
8,000 feet; on return to ground level, the test procedure was repeated for a third 
time.  Ascent and descent rate was 4,000 feet per minute. 
Barometric pressure readings displayed by each handset were recorded 
prior to testing at both ground level and 8,000 feet pressure altitude (Table 15).   
Handset Number Ground Pressure Reading Altitude Pressure Reading 
1 761 mmHg 565 mmHg 
2 760 mmHg 563 mmHg 
3 761 mmHg 564 mmHg 
4 758 mmHg 562 mmHg 
Table 15. Pressure readings recorded by i-Stat device at ground level and 8,000 feet pressure 
altitude 
 
All four handsets were fitted with an EG7+ cartridge; one ampoule of i-
Stat Control 1 test solution was drawn into a syringe and used in each of the test 
cartridges, in accordance with the manufacturer’s instructions.  The results from 
each cartridge were recorded and compared to the published control range for the 
specific test solution.  This process was repeated for the remaining 3 test 
solutions.  Once opened, the ampoule contents were immediately drawn up and 
sampling rapidly performed, to reduce any equilibration of the solution. 
4.2. Results 
Data from the four handsets were in good agreement and, in general, fell 
within the control ranges for each of the test solutions (where provided by Abbott 
Laboratories), both on the ground and at 8,000 feet altitude.  However, 
measurement of the partial pressure of oxygen (pO2) taken at altitude was not in 





agreement.  All pO2 values were lower than those recorded on the ground, with 5 
of the 8 readings below the control range for the specific test solution.  The pO2 
control range for i-Stat Control 1 solution is 9.5-13.5kPa and the pO2 control 
range for i-Stat Control 3 solution is 16.7-22.7kPa.  Results for the four test 
solutions used both on the ground and at 8,000ft altitude are shown in Tables 16-
19.   
 Handset 1 Handset 2 Handset 3 Handset 4 
 Ground 8,000ft Ground 8,000ft Ground 8,000ft Ground 8,000ft 
pH 7.192 7.187 7.188 7.183 7.188 7.184 7.195 7.178 
pCO2 (kPa) 8.25 8.59 8.2 8.51 8.17 8.42 8.23 8.33 
pO2 (kPa) 12.7 9.6 13.5 9.7 13.4 8.7 12.6 9.8 
Base Excess 
(mmol/L) 
-4 -4 -5 -4 -5 -5 -4 -5 
HCO3 
(mEq/L) 
23.7 24.4 23.4 24.0 23.3 23.8 23.9 23.2 
TCO2 
(mmol/L) 
26 26 25 26 25 26 26 25 
SO2 % 95 89 96 89 96 86 95 90 
Table 16. i-Stat Control 1 test solution results for 4 i-Stat handsets on the ground and at 
8,000ft simulated altitude (uncorrected for pO2) 
 
 Handset 1 Handset 2 Handset 3 Handset 4 
 Ground 8,000ft Ground 8,000ft Ground 8,000ft Ground 8,000ft 
pH 7.68 7.678 7.677 7.673 7.678 7.677 7.687 7.674 
pCO2 (kPa) 2.68 2.85 2.66 2.78 2.66 2.74 2.68 2.79 
pO2 (kPa) 19.4 14.3 19.5 14.9 19.2 15.3 19.1 14.9 
Base Excess 
(mmol/L) 
3 5 3 4 3 4 4 4 
HCO3 
(mEq/L) 
23.8 25.1 23.4 24.2 23.4 24.1 24.1 24.2 
TCO2 
(mmol/L) 
24 26 24 25 24 25 25 25 
SO2 % 100 99 100 99 100 99 100 99 
Table 17. i-Stat Control 3 test solution results for 4 i-Stat handsets on the ground and at 
8,000ft simulated altitude (uncorrected for pO2) 
 
 Handset 1 Handset 2 Handset 3 Handset 4 
 Ground 8,000ft Ground 8,000ft Ground 8,000ft Ground 8,000ft 
HCT 17 17 17 17 17 17 17 17 
Table 18. i-Stat Haematocrit Control 1 test solution results for 4 i-Stat handsets on the ground 
and at 8,000ft simulated altitude 
 
 Handset 1 Handset 2 Handset 3 Handset 4 
 Ground 8,000ft Ground 8,000ft Ground 8,000ft Ground 8,000ft 
HCT 54 54 53 54 53 54 53 54 
Table 19. i-Stat Haematocrit Control 3 test solution results for 4 i-Stat handsets on the ground 
and at 8,000ft simulated altitude  






The operating manual provided a correction equation to be calculated 
when using the test solutions at higher altitude environments (Abbott, 2011).  This 
correction is required because the partial pressure of oxygen in the test solution 
changes as it equilibrates with the surrounding environment, so causing a shift in 
pO2 values.  The control range for each test solution is obtained at or near sea 
level, so the adjustments are required if the environmental partial pressure of 
oxygen is reduced.  Once corrected, the observed pO2 values at altitude fell within 
the control ranges, although the values were still considerably lower than those 
recorded at ground level as demonstrated at Figure 13. 
 
Figure 13. Comparison of pO2 results obtained at ground level with corrected results 
obtained at 8,000 feet pressure altitude, using i-Stat Control Solutions 1 and 3 
 
 As there were only 4 data sets obtained for each of the four test solutions, this 
was considered to be insufficient to provide meaningful/valid statistical analysis, 












 Changes in the pO2 results at reduced barometric pressure were 
considerable, even after the values were corrected for the higher altitude.  This is 
due to the equilibration of the oxygen in the aqueous solution to the surrounding 
lower pressure environment.  Throughout the experimental procedure, all test 
solutions were rapidly drawn up into a syringe once the vials were opened and 
applied to the test cartridges immediately, to reduce the time the solution was 
exposed to the atmosphere, but it is clear that a rapid rate of equilibration 
occurred.   
 In the operating manual, Abbott (2011) suggests that the rate of 
equilibration is faster in the aqueous solution because it does not contain any 
haemoglobin to hold the oxygen molecules within the solution.  Whole blood 
taken for sampling in the i-Stat would contain haemoglobin which would bind the 
oxygen molecules, potentially slowing the rate of equilibration with the 
surrounding atmosphere.  However, it is unknown how long it would take for a 
blood sample to equilibrate, if left for any period of time.  From this experiment, it 
is not possible to confirm the accuracy of the i-Stat in calculating pO2 values from 
a patient blood sample at altitude.  Delays in analysing any drawn blood may lead 
to an inaccurate result, which could have clinical implications for patient 
management in-flight.  Current practice for CCAST personnel is to perform the 
blood gas analysis as soon after drawing the blood sample as possible, capping the 
syringe prior to testing.  The i-Stat is primed ready to receive the sample prior to 
the blood sample being drawn from the patient.  It has been suggested that time 





from drawing the sample to commencing the analysis is less than 1 minute 
(Personal communication McLeod/Rose September 2015). 
 Conclusion: In general, values determined from samples analysed by the 
i-Stat were accurate at a pressure altitude of 8,000ft.  However, the calculation of 
pO2 values using the i-Stat control solutions is underestimated at altitude, 
requiring a correction equation to be used, to adjust for the reduced barometric 
pressure at altitude.  When measurements are made using whole blood, the effect 
of equilibration of the test sample in the atmosphere may be less, due to the 
presence of haemoglobin to bind the oxygen, slowing the rate of equilibration.  
Although an underestimate of pO2 is inherently safer than an overestimate, it is 
recommended that the operational and clinical importance of this finding is 
investigated further with the use of whole blood samples.  It is suggested that 
blood samples could be drawn from healthy volunteers at ground level and 
analysed using the i-Stat.  Using the same sample, the analysis could be repeated 
after 5 minutes to monitor for any changes in the results obtained.  Following a 
simulated ascent to 8,000feet in the hypobaric chamber, a second sample could be 
drawn from the same volunteers and analysed, to compare with the ground result.  
Again, the analysis could be repeated from the same sample five minutes later to 
observe any effect of equilibration.  As a definitive comparison, blood samples 
could be obtained both on the ground and at altitude directly into a blood bottle, 
for appropriate laboratory analysis to compare with the results obtained from the 
i-Stat.  This would provide information on the rate of equilibration in whole blood 
at altitude, which might have implications for current CCAST practice, if it 
proved to be significant. 





5. AN INVESTIGATION OF CHANGES IN TISSUE OXYGEN 
SATURATION DURING EXPOSURE TO SIMULATED 
ALTITUDE AND LOWER BODY NEGATIVE PRESSURE 
 
5.1.  Methods 
 
The aim of this second phase of the study was to record tissue oxygen 
saturation in healthy volunteers, who were exposed to both simulated altitude and 
conditions simulating altered circulating volume (utilising lower body negative 
pressure), with the objective of identifying whether regional changes in tissue 
oxygen saturation occur in response to the experimental conditions and if the 
monitoring system selected is sensitive enough to detect any changes in tissue 
oxygen saturation that may occur.  The protocol was designed to assess one tissue 
oxygen saturation monitoring technique in volunteers subjected to conditions 
resembling those experienced by AE casualties. 
 
Study protocol: The study protocol was submitted to and approved by the 
RAF Experimental Medicine Scientific Advisory Committee and the Ministry of 
Defence Research Ethics Committee (MoDREC reference 127/Gen/10). 
 
Subjects: Twelve healthy volunteers were recruited from the population of 
military personnel serving at Royal Air Force (RAF) Henlow.  In order to make 
this phase of the study relevant to the later phase, only subjects between the ages 
of 18 and 40 years were recruited, as the majority of military AE casualties from 
the operational setting fall within this age range.  Individuals with pre-existing 
health problems or those taking prescribed medication were excluded from the 





study.  All subjects completed a health questionnaire to ensure medical fitness to 
undertake the study; written consent was obtained from all subjects.  The EMSAC 
members had requested the inclusion into the protocol of an instruction to the 
volunteers to refrain from products containing caffeine prior to testing, but this 
was removed from the protocol on the instruction of the MoDREC who stated that 
the volunteers should “maintain normal caffeine intake rather than change their 
normal behaviour” (McLeod/Linton correspondence 12 March 2010).  The 
volunteers’ smoking history was added to the pre-screening health questionnaire 
at the request of MoDREC although no restrictions on pre-testing smoking were 
set.  No other exclusion criteria were applied. 
 
Experimental procedure:  The 12 volunteers were subjected to 3 sets of 
tests over 3 separate sessions, at least 24 hours apart.  The three tests were a 
hypoxia altitude simulation test (HAST), a lower body negative pressure test 
(LBNP) and one test combining HAST and LBNP.  All volunteers were instructed 
to abstain from products containing alcohol during the 12 hours before testing.  
A variety of physiological variables were recorded (Table 20) including 
non-invasive beat to beat systolic/diastolic blood pressure, mean arterial pressure, 
heart rate, SpO2 and tissue oxygen saturation.  End tidal expiratory oxygen and 
carbon dioxide concentrations were also recorded via the respiratory mass 
spectrometer as a surrogate of alveolar oxygen and carbon dioxide values.  Blood 
pressure, heart rate and SpO2 were measured on the right arm and tissue oxygen 
saturation was measured from the left arm. 
 





Variable Measurement Technique 
Peripheral arterial oxygen saturation 
Heart rate 
Systolic/Diastolic blood pressure 
End tidal oxygen concentration 
End tidal carbon dioxide concentration 
Tissue oxygen saturation 
Kontron pulse oximeter 
Kontron pulse oximeter 
FMS Finometer 
LR-1 Respiratory mass spectrometer 
LR-1 Respiratory mass spectrometer 
INVOS 5100C cerebral / somatic monitor 
Table 20. Measured variables during hypoxia altitude simulation test and lower body 
negative pressure test 
 
The volunteers were fitted with a close fitting RAF P/Q oro-nasal oxygen 
mask and each one was asked to lie supine on the tilt table.  Arm rests were fitted 
to the sides of the table (at mid-axillary level) to support the volunteer’s arms.  A 
Kontron pulse oximeter (Kontron, Watford, UK) sensor clip was applied to the 
volunteer’s right index finger to record SpO2 and heart rate.  Tissue oxygen 
saturation was measured from the upper third of the left upper arm, lateral aspect 
– over the deltoid muscle, using a self-adhesive, single use, non-invasive probe 
connected to the INVOS monitor (Somanetics, Troy, MI, USA).  End tidal 
expiratory oxygen and carbon dioxide concentrations were measured by inserting 
the mass spectrometer capillary into a tapping in the P/Q mask cavity.  The 15.1% 
oxygen cylinders were positioned at the head of the tilt table. 
Non-invasive beat to beat systolic/diastolic blood pressure monitoring was 
undertaken using the Finometer monitoring system (FMS, Arnhem, The 
Netherlands), which was selected for use in the current study as it is able to 
monitor rapid changes in blood pressure, which other monitoring systems 
(utilising oscillatory techniques) might be slower to detect (Vos, Poterman et al, 
2014).  An inflatable cuff was applied to the volunteer’s right middle finger 
between the PIP and DIP joints.  The finger cuff calculates finger arterial pressure 
through changes in the absorption of infra-red light from an LED located within 





the cuff.  Changes in arterial diameter in the finger occur in response to the phases 
of the cardiac cycle and these can be identified from alterations in the infra-red 
light absorption.  A pneumatic servo attached to the cuff inflates or deflates a 
bladder inside the cuff to apply a counter-pressure to prevent these changes in the 
arterial diameter in the finger, keeping it at a known diameter – the ‘set point’.  A 
Physiocal algorithm is built into the Finometer system to periodically adjust the 
‘set point’ to account for changes in tone in the smooth muscle of the finger artery 
wall, which may be seen in response to alterations in temperature or haematocrit 
for example (FMS, 2005).  Through this method, cuff pressure changes can be 
monitored, providing an indirect measurement of intra-arterial pressure, which is 
reconstructed as the brachial arterial pressure.  The Finometer software calculates 
systolic, diastolic and mean blood pressure in this beat to beat method (Imholz et 
al, 1998).  An additional arm cuff is used to further calibrate the reconstructed 
brachial pressure (Guelen et al, 2003); this cuff was applied to the right upper arm 
for calibration readings prior to the start of the experimental phases and was 
removed once the readings were obtained.  The volunteer’s weight, height, age 
and gender were entered into the Finometer Modelflow software, which permits 
the individual estimation of aortic flow and therefore stroke volume.  The 
software calculates cardiac output on a beat to beat basis, using the estimated 
stroke volume and the measured heart rate (Jansen et al, 2001).  Clinically, cardiac 
index is a method of normalising cardiac output to body surface area, but as the 
experimental phase was recording intra-subject measurements (ie repeated 
measures) this normalisation was not required, so cardiac output readings are 
reported throughout.  Volunteers whose fingers/hands felt cool to the touch were 





provided with commercially available hand warming packs pre-experiment to 
warm their upper extremities to aid data collection via the Finometer. 
   
 a)  Hypoxia Altitude Simulation Test (HAST).  The HAST or hypoxic 
challenge test was developed for use in patients with pre-existing respiratory 
conditions, to identify those who would require supplemental oxygen during 
commercial flights (British Thoracic Society, 2011).  The test involves breathing a 
15.1% oxygen gas mix through a tight fitting mask whilst monitoring peripheral 
arterial oxygen saturation (SpO2) readings.  This hypoxic gas mixture simulates 
the in-flight partial pressure of inspired oxygen at 8000 feet cabin altitude; 
supplemental in-flight oxygen can then be supplied for those patients who 
demonstrate a significant drop in SpO2 during the test. 
An alternative method of exposing the subjects to hypoxia would have 
been in the hypobaric chamber; however, the HAST is a less resource-intensive 
method, carries fewer potential risks for the subjects and can be more readily 
integrated with the LBNP test. 
Baseline monitoring of the physiological parameters was undertaken for 5 
minutes.  After this time, the 15.1% oxygen mix was administered for a 20 minute 
period, via an aircraft demand oxygen regulator.  At the end of the 20 minutes, 
volunteers reverted to breathing room air and were monitored for a further 10 
minute recovery period.     
 
b)  Lower Body Negative Pressure Test (LBNP).  LBNP can be used as a 
research tool to simulate haemorrhage or hypovolaemia; the application of 
negative pressure to the lower body diverts blood flow away from the upper body, 





inducing a similar physiological response seen in casualties during acute 
haemorrhage (Soller et al, 2008a).  It is estimated that the application of 40 to 
60mmHg lower body negative pressure simulates blood loss of approximately 
1000ml (Cooke, Ryan and Convertino, 2004).  It is impossible to fully replicate in 
the laboratory the clinical conditions experienced by AE casualties; indeed, the 
LBNP test is more extreme, since most AE patients should be stabilised prior to 
flight, but it provides a useful analogue for research purposes. 
The volunteers were fitted with the same physiological monitoring devices 
as previously described (Table 20).  They were placed in a supine position in the 
LBNP device, with an airtight skirt seal fitted over the iliac crest (Figure 14).  An 
initial five minute period of baseline monitoring was recorded.  After this time, 
the volunteers were subjected to 5 minute (non-randomised) stepped intervals of 
lower body negative pressure at 20, 40 and 60mmHg.  On completion of the 
LBNP test, the subjects were monitored for a ten minute recovery period (Figure 
15). 
c)  HAST and LBNP Combination.  During this test, the subjects were fitted 
with physiological monitoring as previously described (Table 20) and with the 
RAF P/Q oro-nasal oxygen mask.  They were placed in a supine position in the 
LBNP device, with the skirt seal over the iliac crest.  After a five minute period of 
baseline monitoring, the 15.1% oxygen mix was started through the mask.  After 5 
minutes, the volunteers were then subjected to 5 minute (non-randomised) stepped 
intervals of lower body negative pressure at 20, 40 and 60mmHg.  On completion 
of the LBNP test, the oxygen mix was terminated and the subjects were monitored 
for a ten minute recovery period (Figure 15). 







Figure 14. Study volunteer undergoing lower body negative pressure test in conjunction with 
























Figure 15. Flow charts demonstrating the 3 test conditions used in phase 2a of the study 
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Termination of an experimental run: It was decided that an experimental 
run would be terminated if: 
a. The volunteer exhibited signs or symptoms of impending cardiovascular 
collapse, defined as one or more of the following: 
(i) a sudden decrease  in systolic blood pressure (greater than 15mmHg) 
(ii) a sudden decrease in heart rate (greater than 15 beats per minute) 
(iii) a reduced systolic blood pressure below 80mmHg 
(iv) a reduced conscious level 
b. The volunteer self-terminated due to the onset of pre-syncope (altered vision, 
sweating, nausea or dizziness). 
 
The order for the three experimental conditions is shown in Table 21.  
Presentation of each experimental condition was balanced over the three 
conditions in six casualties, according to a Latin Square design.  This was 
repeated to include a total of twelve subjects. 
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Table 21. Order of experimental conditions for 12 subjects 
HAST = hypoxia altitude simulation test; LBNP = lower body negative pressure test; HAST & 
LBNP = both tests in combination. 
 
 





Data collection: Continuous live data from the pulse oximeter, Finometer cuff 
and respiratory mass spectrometer were captured by a digital data acquisition 
system at a sample rate of 200Hz (LabChart
®
 7, ADInstruments Ltd).  The 
INVOS 5100C cerebral / somatic monitor recorded measurements every six 
seconds to an internal file; these were later exported into a Microsoft
©
 Office 
Excel file.  Event markers were used to synchronise timings between the 2 
sources.  Data reduction was achieved by calculating the mean measurement of all 
variables for each minute of recording. 
 
Data analysis was undertaken utilising Stata SE 12.1 software (StataCorps, 
Texas, USA).  Initially box and whisker plots were calculated using the Stata 
software.  Regression analysis was used to explain the changes in physiological 
variables in terms of simulated altitude (HAST) and a simulated altered 
circulating volume (increasing levels of LBNP).  A separate model was fitted for 
each experiment.  The mean of the final minute of readings for each variable at 
each experimental phase for the twelve volunteers were used in the analysis.  A 
value of p<0.05 was considered to be statistically significant. 
5.2.  Results 
 
Demographic and anthropometric data for the twelve volunteers are shown 
in Table 22. 
 Variable 
Age (years) 
Gender (n) (male / female) 
Height (cm) 
Weight (Kg) 
31.2 (Range 23 – 40) 
10 / 2 
175.9 ±7.8 
76.6 ±10.3 
Table 22. Demographic and anthropometric data for phase 2a; n = 12 
Values are means ±SD. 





All twelve volunteers completed the three experimental conditions; one 
volunteer terminated the combined HAST and LBNP test after 1 minute at 
60mmHg LBNP, due to symptoms of pre-syncope.  The final complete minute of 
readings for this individual were used in the analysis.  There were no adverse 
effects experienced by the twelve volunteers as a result of the experimental 
conditions. 
As an initial review of the data, separate graphs were drawn, 
demonstrating the effect of each experimental condition on individual 
physiological parameters, to observe any trends demonstrated over time.  A full 
set of graphs can be found at Annex D, with selected findings discussed below. 
 
Figure 16 depicts tissue oxygen saturation monitoring recorded from the 
left deltoid muscle in the twelve volunteers during administration of the 15.1% 
oxygen mix with the addition of increasing lower body negative pressure.  
Measurements were recorded every 6 seconds; this graph displays the mean of 
each minute of recording for each volunteer.  In the majority of volunteers, a 
downward trend can be seen, which began with the start of the 15.1% oxygen mix 
and continued as LBNP was commenced and then increased.  Once the LBNP and 
oxygen mix were terminated, there was an immediate response in tissue oxygen 
saturation, with a sharp upward turn, before the readings returned to pre-test 
levels.  This effect was seen earlier in subject L who terminated the final test 
phase early.  Two subjects demonstrated only small changes in tissue oxygen 
saturation monitoring during the combined experiment. 






Figure 16. Mean tissue oxygen saturation recorded at the left deltoid in 12 volunteers during 
exposure to both HAST and LBNP 
HAST = Hypoxia altitude simulation test; LBNP = Lower body negative pressure. 
 
 
Figure 17 depicts the mean heart rate recorded in the twelve volunteers 
during exposure to 3 stepped intervals of lower body negative pressure.  
Continuous data was recorded; the graph depicts the mean of each minute of 
recording for each volunteer.  A gradual increase in heart rate was seen in all 
volunteers in response to the increasing levels of LBNP; this effect was quickly 
reversed at the termination of LBNP with mean heart rates returning to pre-test 
levels during the recovery phase. 










 Figure 18. Mean peripheral arterial oxygen saturation in 12 volunteers during exposure to 









Figure 18 above demonstrates the trend in mean peripheral arterial oxygen 
saturation recordings in the 12 volunteers during exposure to both LBNP and 
HAST.  With the exception of one volunteer, there was a general downward trend 
in mean SpO2 readings, primarily in response to the reduced oxygen mix 
administered at the start of the test.  Again, an immediate improvement in 
readings was seen once the experimental conditions were terminated.  It is 
suggested that Subject M may have had an ill-fitting mask, which allowed room 
air into the mask cavity, altering the 15.1% oxygen mix being administered, 
which would account for the lack of response seen. 
 
To further investigate the effect of each experimental condition on 
individual physiological responses, box and whisker plots were generated, using 
the mean physiological readings for the final minute of each phase of the 
experimental condition. 
Figure 19 below demonstrates the effect of the reduced oxygen mix on 
SpO2 during the hypoxia altitude simulation test, with the median SpO2 falling 
from 98% to 92%.  Regional tissue oxygen saturation also fell during HAST.  A 
slight increase in respiratory rate, heart rate and cardiac output were seen in 
response to the reduced oxygen mix. 
 






Figure 19. Mean peripheral arterial oxygen saturation recorded in 12 volunteers during 
hypoxia altitude simulation test 
Mean readings for the final minute of each phase of the experiment; outlier shown in blue below 




Figure 20. Mean heart rate recorded in 12 volunteers during exposure to lower body 
negative pressure 
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As shown in Figure 20 above, heart rate increased in response to stepped 
intervals of lower body negative pressure.  This response was terminated with the 
cessation of LBNP, causing heart rates to return to pre-test levels.  Cardiac output 
and rSO2 were seen to fall in response to the LBNP test. 
 
In response to the combined HAST and LBNP test, regional tissue oxygen 
saturation fell, as shown in Figure 21.  Changes were seen in all physiological 
variables during this experimental phase, with decreases recorded in SpO2, mean 
arterial pressure and cardiac output and compensatory increases in heart rate and 
respiratory rate. 
 
Figure 21. Mean tissue oxygen saturation recorded in 12 volunteers during exposure to 
HAST and LBNP in combination 
Mean readings for the final minute of each phase of the experiment 
 
 
 Regression models were fitted to explain the changes in physiological 
variables in terms of simulated altitude (HAST) and a simulated altered 
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The mean of the final minute of readings for each variable at each experimental 
phase for the twelve volunteers were used in the analysis. 
 As shown in Table 23, there were changes in all variables in response to 
the hypoxia altitude simulation test; however, only the decrease in rSO2 and SpO2 















Change in value -4.1 -5.2 1.1 2.4 3.3 0.43 
p-value 0.009** 0.000** 0.298 0.665 0.354 0.533 
Table 23. Mean changes in physiological variables with associated p-values in response to 
hypoxia altitude simulation test 
** indicates p-values <0.01 
 Larger physiological changes were seen in rSO2, heart rate and cardiac 
output in response to the lower body negative pressure test (Table 24).  Although 
the changes were only statistically significant at the highest level of LBNP 
(60mmHg), the coefficients suggest a dose-related response, with a falling cardiac 















Change in value -3.1 0.3 1.7 0.6 1.6 -0.4 
p-value 0.221 0.620 0.154 0.903 0.653 0.430 
40mmHg 
LBNP 
Change in value -3.9 0.4 1.6 0.5 5.9 -0.7 
p-value 0.121 0.397 0.175 0.917 0.095 0.205 
60mmHg 
LBNP 
Change in value -5.5 0.1 1.7 -2.5 20.8 -1.2 
p-value 0.033* 0.822 0.152 0.595 0.000** 0.037* 
Table 24. Mean changes in physiological variables with associated p-values in response to 
lower body negative pressure test 
* indicates p-values <0.05; ** indicates p-values <0.01 
 
 When the volunteers were exposed to HAST in combination with LBNP, 
changes were seen in all physiological variables (Table 25).  Peripheral arterial 
oxygen saturation decreased in response to the 15.1% oxygen mix and remained 





low with the introduction of LBNP, although there did not appear to be any 
evidence of an interaction between HAST and LBNP on SpO2 readings. 
A reduction was seen in regional tissue oxygen saturation readings with 
the start of the 15.1% oxygen mix, although this was not demonstrated to be 
statistically significant.  The rSO2 readings continued to decrease with the 
addition of LBNP, again demonstrating a statistically significant dose-related 
response.  There was some evidence of an interaction between HAST and LBNP 
on rSO2, with larger changes in rSO2 readings seen in the combination test, when 
compared with the individual test conditions. 
The dose-related response of LBNP was also seen in heart rate readings, 
with increases in heart rate as a result of the introduction of the reduced oxygen 
mix and then stepped intervals of LBNP, although only LBNP at 40 and 60mmHg 
proved to be statistically significant. 
Changes in respiratory rate in response to HAST and 60mmHg LBNP in 
combination were shown to be marginally statistically significant and appeared to 
demonstrate some interaction between the two test conditions; however, this 
effect was not clear due to the presence of collinearity. 














Change in value -1.9 -3.9 1.3 1.2 4.7 0.5 
p-value 0.452 0.000** 0.238 0.783 0.467 0.431 
20mmHg 
LBNP/O2  
Change in value -5.7 -4.7 1.6 1.6 3.4 -0.3 
p-value 0.028* 0.000** 0.162 0.707 0.592 0.621 
40mmHg 
LBNP/O2 
Change in value -7.1 -5.1 1.6 -0.5 10.3 -0.7 
p-value 0.006** 0.000** 0.162 0.913 0.111 0.264 
60mmHg 
LBNP/O2 
Change in value -8.5 -4.5 2.3 -6.9 33.5 -1.2 
p-value 0.001** 0.000** 0.049* 0.113 0.000** 0.062 
Table 25. Mean changes in physiological variables with associated p-values in response to 
hypoxia altitude simulation test in combination with lower body negative pressure 
* indicates p-values <0.05; ** indicates p-values <0.01 





5.3.  Discussion 
 
Overall, changes in physiological readings in response to the hypoxia 
altitude simulation test were primarily seen in rSO2 and SpO2 values.  There was 
evidence of a dose-related effect on heart rate, rSO2 and cardiac output seen in 
response to increasing intervals of lower body negative pressure.  This was also 
evident in the combined HAST and LBNP experiment, where changes were seen 
in all variables, although not all were statistically significant.  Regional tissue 
oxygen saturation was the only monitoring technique to demonstrate an effect in 
response to all 3 test conditions, suggesting that it may be more sensitive to 
changes than standard physiological monitoring. 
Analysis of the data showed that peripheral arterial oxygen saturation 
(SpO2) decreased amongst the volunteers during the hypoxia altitude simulation 
test (Figure 19).  In the majority of volunteers, mean individual SpO2 fell from a 
range of 97-100% to 90-94%.  This response was similar to that observed by 
Smith (2007), who monitored SpO2 in six healthy volunteers exposed to an 
altitude of 7,100ft (2743m) in a hypobaric chamber; over a five minute period, 
mean SpO2 fell from over 97% to 92%.  In an earlier study, Cottrell et al (1995) 
recorded SpO2 in 38 airline crew members during scheduled short haul flights and 
identified a fall in SpO2 from a range of 99-95% at ground level, to a range of 92-
87% at 6,000-7,000ft. 
Clumper (2011) describes four stages of hypoxia in relation to altitude, the 
first of which is defined as ‘indifferent hypoxia’, due to the minor physiological 
effects experienced up to an altitude of 10,000 feet.  Healthy individuals 
compensate for the fall in the partial pressure of alveolar air at this altitude by 





increasing respiratory rate and depth (Dine and Kreider, 2008; Lyznicki et al, 
2000), through the hypoxic stimulation of arterial chemoreceptors (Levick, 2010); 
mild tachycardia is also commonly reported (Clumper, 2011).  There were small 
increases in respiratory rate, heart rate and cardiac output recorded amongst the 
volunteers during the hypoxia altitude simulation test, although the responses 
were not statistically significant. 
The results shown in Table 23 suggest that the majority of volunteers 
demonstrated a significant fall in tissue oxygen saturation recorded in the left 
deltoid in response to the hypoxia altitude simulation test.  The paucity of 
previous studies utilising tissue oxygen saturation monitoring at altitude means 
there are few data available to permit comparison of the results obtained.  
However, the majority of volunteers demonstrated similar trends in response to 
the reduced oxygen mix, suggesting a common physiological response to 
simulated altitude.  The results suggest that a fall in systemic oxygenation at 
simulated altitude (measured using SpO2) is associated with a reduction in 
regional tissue oxygen saturation. 
 
In the present study, lower body negative pressure did not have an effect 
on SpO2.  This lack of response was also reported by Soller et al (2008a). 
 
The body’s immediate response in recognising hypovolaemia involves the 
chemoreceptors and baroreceptors.  A fall in the circulating volume of blood 
causes a decrease in the ventricular end diastolic volume, which reduces cardiac 
contractility, causing a fall in stroke volume (in accordance with Starling’s Law) 





and pulse pressure.  If uncorrected, this would lead to a fall in cardiac output and 
arterial blood pressure, subsequently affecting cerebral and myocardial perfusion 
with potentially catastrophic consequences.  This is identified by a reduction in 
baroreceptor activity, which effects a decrease in vagal nerve activity and an 
increase in sympathetic activity, causing vaso- and veno-constriction in the 
cutaneous, skeletal muscle, splanchnic and renal circulation to redistribute blood 
into the central circulation to improve venous return and cardiac filling, which 
increases peripheral vascular resistance (Levick, 2010).  A reflex tachycardia in 
combination with this vaso-constriction helps to maintain mean arterial pressure, 
to preserve cerebral and cardiac perfusion (Ernsting et al, 2006; Lott et al, 2009).  
Sympathetic stimulation also triggers the release of adrenaline and noradrenaline 
which act to increase heart rate and cardiac contractility, contributing to the 
maintenance of mean arterial pressure.  Decreased blood flow to the tissues during 
hypovolaemia results in the development of metabolic acidosis.  The 
chemoreceptor response to this metabolic acidosis (and reduced oxygenation of 
the chemoreceptors themselves) is to increase the rate and depth of respiration to 
improve gas exchange and restore a normal blood pH.  Chemoreceptor response 
also supports peripheral vasoconstriction to maintain MAP.  Later responses to 
hypovolaemia, such as renal fluid retention, are not considered in the context of 
the present study. 
LBNP is acknowledged as an appropriate means to simulate the body’s 
immediate response to hypovolaemia (Soller et al, 2008a; Cooke et al, 2004).  
However, the circulating volume is not lost from the body with LBNP as would 
occur with hypovolaemia; blood is redistributed from the thorax into the pelvis 





and legs (Cooke et al, 2004), with blood vessels, predominantly in the muscles, 
‘stretching’ to accommodate the extra volume (Hachiya et al, 2012).  This reduces 
cardiac filling which then induces the body’s response as described above.     
Cardiovascular responses to lower body negative pressure were not seen, 
with one exception – heart rate increased significantly in response to the highest 
level of LBNP.  The trend effect of LBNP on mean arterial pressure, heart rate 
and cardiac output appeared to be dose-related and may have become significant 
with an additional level of LBNP.  Soller et al (2008b) identified a similar 
response in MAP to LBNP – changes in MAP became statistically significant 
once the LBNP level reached 90mmHg; changes in heart rate became significant 
at 60mmHg as was seen in the present study.  This was also reported in a study by 
Ryan et al (2008), who demonstrated that significant changes in heart rate, 
systolic and diastolic blood pressure were seen at 60mmHg LBNP, but changes in 
mean arterial pressure were not observed until LBNP was increased to 80mmHg.  
This preservation of MAP and CO through the body’s immediate response to 
simulated hypovolaemia can be observed within the present study, with only small 
changes in CO and MAP recorded.        
The graph at Figure 21 showed a downward trend in tissue oxygen 
saturation in response to the hypoxia altitude simulation test in combination with 
increasing lower body negative pressure.  Constriction of the peripheral blood 
vessels occurs to maintain core perfusion and oxygenation, which reduces 
oxygenation of the peripheral tissues – as shown by the falling rSO2 readings.  
Once LBNP and HAST were terminated, there was a sharp upward trend in 
readings, above the pre-test levels, as blood flow and perfusion improved in the 





upper body.  Tissue oxygen saturation returned to values similar to those seen pre-
test as the blood vessels then constricted to maintain blood pressure and cardiac 
output.  Analysis of the data seemed to suggest that combined LBNP and HAST 
had a greater effect on tissue oxygen saturation, than either test in isolation, with 
the combined test demonstrating a greater reduction in mean rSO2 values than 
HAST or LBNP alone.  Again, a lack of prior published studies examining rSO2 at 
altitude prevents any comparison of the results obtained.  This greater combined 
effect could have significance for the casualty with an altered circulating volume 
following traumatic injury who is then exposed to altitude; a larger fall in rSO2 
suggests a greater reduction in peripheral perfusion, potentially leading to tissue 
damage and a less favourable outcome – perhaps resulting in an increased 
requirement for debridement of devitalised tissue, a higher amputation, or organ 
failure. 
Correct positioning of the volunteers in the LBNP device was essential, to 
ensure that the airtight skirt seal was positioned over the iliac crest rather than the 
upper abdominal area, to reduce any measurement error as a result of the incorrect 
application of LBNP.  Goswami et al (2009) reported increased haemodynamic 
responses in volunteers exposed to LBNP where the skirt seal had been positioned 
over the abdomen when compared with responses from volunteers exposed to 
LBNP with a seal over the iliac crest.      
  
Limitations: A limitation of the present study was the inability to 
reproduce the exact conditions experienced by AE casualties; although the 
application of LBNP produces a hypovolaemic response within the body (Soller et 





al 2008b), it doesn’t take account of other factors such as pain or inflammatory 
responses or replicate tissue damage seen in traumatic injuries or the ensuing 
biochemical effects on the body (Cooke et al, 2004).  For the purposes of this 
study, however, the use of LBNP to produce an altered circulating volume in the 
volunteers was sufficient to introduce a physiological response which was 
identified and reported by the tissue oxygen saturation monitor being tested. 
 
Conclusion: The aim of this second phase of the study was to record tissue 
oxygen saturation in healthy volunteers, who were exposed to both simulated 
altitude and conditions simulating altered circulating volume, with the objective 
of identifying whether regional changes in tissue oxygen saturation occur in 
response to the experimental conditions and if the monitoring system selected is 
sensitive enough to detect any changes in tissue oxygen saturation that may occur.  
The data obtained suggests that regional changes in tissue oxygenation do occur in 
response to the test conditions and that the rSO2 monitoring technique is sensitive 
enough to detect those changes, and would therefore be suitable for use in the 
observational study planned for phase 3. 





6. AN INVESTIGATION OF CHANGES IN TISSUE 
OXYGEN SATURATION DURING EXPOSURE TO 
SIMULATED ALTITUDE AND LOWER BODY 
NEGATIVE PRESSURE AND TILT 
 
6.1.  Methods 
 
Background: In phase 2a, lower body negative pressure and / or a hypoxia 
altitude simulation test were used to assess the effectiveness of the INVOS 5100C 
cerebral / somatic oximeter in identifying changes in tissue oxygen saturation in 
volunteers exposed to these test conditions.  The monitoring system proved to be 
effective in identifying changes in tissue oxygen saturation seen in response to the 
test conditions and could therefore be used in the observational study proposed for 
phase 3 of this research.  As an extension of this earlier study, an additional 
experimental phase was proposed.  Critical care casualties escorted by a CCAST 
are generally transported head first in-flight (i.e. with their heads pointing towards 
the cockpit), in contrast to non-critical aeromed patients who travel feet first.  It 
was hypothesised that, in casualties already experiencing an altered circulating 
volume as a result of their injuries, this head first position, which exposes the 
casualties to a head up tilt during take-off, and other phases of flight, may lead to 
a reduction in upper body regional tissue oxygen saturation.  During a study in 
which 16 casualties underwent transthoracic bioreactance monitoring throughout 
their aeromedical evacuation with the French Air Force, Dubost et al (2013) 
identified a decrease in median cardiac index during and immediately after take-
off.  They suggested that the supine casualty, travelling head first, may be 
subjected to a greater physiological challenge as a result of acceleration loads 





during take-off, particularly when departing from operational locations where the 
rate of ascent increases more rapidly than would otherwise be experienced. 
Non-ventilated patients travel feet first on the C-17 aircraft, as the Patient 
Service Module (PSM), which contains the emergency decompression oxygen 
system, is located on the aft stretcher stanchion.  As ventilated patients do not 
require access to the PSM in the event of a rapid decompression, as they are 
already receiving supplemental oxygen, they are permitted to travel head first on 





Aim: The aim of this additional experimental phase was to record tissue 
oxygen saturation in healthy volunteers, exposed to lower body negative pressure, 
HAST and a head up tilt, with the objective of identifying whether regional 
changes in tissue oxygen saturation occur in response to the experimental 
conditions and if the monitoring system selected is sensitive enough to detect any 
changes in tissue oxygen saturation that may occur.   
 
Study protocol: The study protocol was submitted to and approved by the 
RAF Experimental Medicine Scientific Advisory Committee and the Ministry of 
Defence Research Ethics Committee (MoDREC reference 127/Gen/10). 
 
Subjects: Twelve healthy volunteers were recruited from the population of 
military personnel between the ages of 18 and 40 years, who are currently serving 
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at RAF Henlow.  Individuals with pre-existing health problems or those taking 
prescribed medication were excluded from the study.  All subjects completed a 
health questionnaire to ensure medical fitness to undertake the study; written 
consent was obtained from all subjects.  As a result of the information provided in 
the health questionnaire, one volunteer was withdrawn from the study. 
 
Experimental procedure:  The 11 volunteers were subjected to 2 tests on 
2 separate days, at least 24 hours apart.  One test combined HAST and LBNP as 
described in phase 2a of the study, with the same physiological monitoring as 
previously defined (Table 26), although the Kontron pulse oximeter probe was 
fitted to the left index finger and the Finometer cuff to the left middle finger, as 
the right arm was being used to simultaneously collect data for a separate research 
project.  The second test was HAST and LBNP in combination, with the addition 
of a 70° head up tilt after 5 minutes at 20mmHg LBNP (Figure 22).  Manual 
tilting of the table took approximately 5 seconds to achieve.  Once the table was 
tilted, the volunteers spent a further 5 minutes at 20mmHg LBNP, followed by 5 
minute stepped intervals of LBNP at 40 and 60mmHg, with the tilt maintained.  
At the end of the testing, the table was lowered to a supine position, with the 
termination of LBNP; the volunteers reverted to breathing room air and were 
monitored during a 10 minute recovery period.  
Variable Measurement Technique 
Peripheral arterial oxygen saturation 
Heart rate 
Systolic/Diastolic blood pressure 
End tidal oxygen concentration 
End tidal carbon dioxide concentration 
Tissue oxygen saturation 
Kontron pulse oximeter 
Kontron pulse oximeter 
FMS Finometer 
LR-1 Respiratory mass spectrometer 
LR-1 Respiratory mass spectrometer 
INVOS 5100C cerebral/somatic monitor 
Table 26.  Measured variables during hypoxia altitude simulation test and lower body 
negative pressure test 





Termination of an experimental run: It was decided that an experimental 
run would be terminated if: 
a. The volunteer exhibited signs or symptoms of impending cardiovascular 
collapse, defined as one or more of the following: 
(i) a sudden decrease in systolic blood pressure (greater than 15mmHg) 
(ii) a sudden decrease in heart rate (greater than 15 beats per minute) 
(iii) a reduced systolic blood pressure below 80mmHg 
(iv) a reduced conscious level 
b. The volunteer self-terminated due to the onset of pre-syncope (altered 
vision, sweating, nausea or dizziness). 
 
Figure 22. Flow chart demonstrating the 2 test conditions used in phase 2b of the study 




LBNP & HAST 
 
10 minute baseline monitoring 
 
 
5 minutes administration of 
15.1% oxygen mix 
 
 
5 minutes at 20mmHg LBNP 
with oxygen mix 
 
 
5 minutes at 40mmHg 
LBNP with oxygen mix 
 
 
5 minutes at 60mmHg LBNP 
with oxygen mix 
 
 
10 minute recovery period 
 
LBNP & HAST WITH TILT 
 
10 minute baseline monitoring 
 
 








5 minutes at 20mmHg LBNP with 
oxygen mix and 70° HUT 
 
 
5 minutes at 40mmHg 
LBNP with oxygen mix and HUT 
 
 
5 minutes at 60mmHg LBNP with 
oxygen mix and HUT 
 
10 minute recovery period 
 





The order for the two experimental conditions is shown in Table 27 below. 
 













HAST & LBNP 
HAST & LBNP with HUT 
HAST & LBNP 
Withdrawn from study 
HAST & LBNP 
HAST & LBNP with HUT 
HAST & LBNP 
HAST & LBNP with HUT 
HAST & LBNP 
HAST & LBNP with HUT 
HAST & LBNP 
HAST & LBNP with HUT 
HAST & LBNP with HUT 
HAST & LBNP 
HAST & LBNP with HUT 
Withdrawn from study 
HAST & LBNP with HUT 
HAST & LBNP 
HAST & LBNP with HUT 
HAST & LBNP 
HAST & LBNP with HUT 
HAST & LBNP 
HAST & LBNP with HUT 
HAST & LBNP 
Table 27.  Order of experimental conditions for 12 subjects 
HAST = hypoxia altitude simulation test; LBNP = lower body negative pressure test; HUT = 70° 
head up tilt. 
 
 
Data collection: Data collection, reduction and analysis were undertaken 
using the processes previously described in Chapter 5.      
 
6.2.  Results 
Demographic and anthropometric data for the eleven volunteers are shown 




Gender (n) (male / female) 
Height (cm) 
Weight (Kg) 
29.7 (Range 23 – 37) 
9 / 2 
172.9 ±6.46 
76.2 ±10.94 
Table 28. Demographic and anthropometric data for phase 2b; n = 11 
Values are means ±SD. 
 
All eleven volunteers completed both experimental conditions; one 
volunteer terminated the combined HAST and LBNP test before completing a full 
5 minutes at 60mmHg LBNP, due to symptoms of pre-syncope.  Four volunteers 
terminated the combined HAST, LBNP and tilt test before completing a full 5 





minutes at 60mmHg LBNP, also due to symptoms of pre-syncope.  In these cases, 
the final complete minute of readings were used in the data analysis.  There were 
no adverse effects experienced by the eleven volunteers as a result of the 
experimental conditions. 
Tissue oxygen saturation readings in 1 volunteer were very low compared 
with other volunteers and with the previous study; taken in combination with a 
low signal strength indicator on the INVOS oximeter, these low readings were 
interpreted as erroneous due to a poor connection.  Despite replacing the sensor, 
the rSO2 signal strength indication for this volunteer did not improve, so the rSO2 
results were excluded from the final analysis. 
A full set of graphs can be found at Annex E, with selected findings 
discussed below.    
 When the volunteers were exposed to HAST in combination with LBNP 
and tilt, changes were seen in all physiological variables (Table 29).  Peripheral 
arterial oxygen saturation decreased in response to the 15.1% oxygen mix and 
remained low with the introduction of LBNP and then tilt, although there did not 
appear to be any evidence of an interaction between the test conditions on SpO2 
readings. 
Regional tissue oxygen saturation readings showed a decreasing trend with 
the administration of the 15.1% oxygen mix, although this was not shown to be 
statistically significant.  Further decreases in rSO2 readings were noted with the 
introduction of LBNP and tilt, with a greater response seen with higher levels of 
LBNP, as previously noted in phase 2a. 
 





The dose-related effect of LBNP and tilt were also seen in heart rate 
readings, with increases in heart rate seen at all phases of the experiment, 
although these increases only became statistically significant at 40 and 60mmHg 
LBNP with tilt.  Dose-related changes in cardiac output and mean arterial pressure 
were also seen at the higher levels of LBNP and tilt.   
Individual increases in heart rate combined with a fall in MAP and CO 
were extreme enough for a number of the volunteers to terminate the test phase 
before completing the full 5 minutes at 60mmHg LBNP with tilt. 
















Change in value -1.6 -3.1 -2.4 1.7 4.8 0.6 
p-value 0.669 0.003** 0.104 0.750 0.367 0.227 
20mmHg 
LBNP/O2  
Change in value -5.2 -3.6 -2.1 1.9 5.9 -0.7 




Change in value -6.3 -4.4 -2.2 3.2 8.8 -0.2 




Change in value -6.9 -3.8 -1.5 -0.7 19.2 -0.6 




Change in value -8.0 -3.9 -1.0 -15.3 34.6 -1.9 
p-value 0.035* 0.000** 0.487 0.005** 0.000** 0.000** 
Table 29. Mean changes in physiological variables with associated p-values in response to 
hypoxia altitude simulation test in conjunction with lower body negative pressure and head 
up tilt 
* indicates p-values <0.05; ** indicates p-values <0.01 
6.3.  Discussion 
 
In summary, adding a 70° head up tilt to the combined HAST and LBNP 
experimental procedure used in phase 2a of the study did elicit some physiological 
changes, primarily seen in the cardiovascular variables - heart rate, cardiac output 
and mean arterial pressure.  An increase in heart rate and a corresponding fall in  
cardiac output and mean arterial pressure were recorded, which proved to be 





statistically significant at the highest level of LBNP when combined with HAST 
and tilt.  Changes in the coefficients for rSO2, SpO2 and respiratory rate were 
consistent with the results seen with the HAST and LBNP only combination, 
suggesting that adding a head up tilt did not greatly effect these variables. 
Cooke and Convertino (2002) suggest that the physiological sympathetic 
response is withdrawn (in healthy volunteers) at the point when the body cannot 
further increase peripheral vascular resistance in response to a continued stimulus 
such as LBNP.  They postulate that the withdrawal of sympathetic activity, which 
results in peripheral vasodilation, leading to syncope, is the body’s way of 
restoring cerebral perfusion when increasing peripheral vascular resistance has 
failed to do so. 
It is suggested that the fall in mean CO and MAP observed during this 
phase of the study result from the body’s inability to further compensate for 
LBNP and tilt and would likely have resulted in syncope had the experimental 
conditions not been terminated.  This suggestion is supported by the fact that 4 
volunteers terminated the final experimental phase before completion of the full 5 
minutes due to symptoms of impending syncope.  Hachiya et al (2004) suggest 
that a head up tilt between 60-70° is equal to LBNP of 40mmHg, indicating that 
the volunteers in the present study were exposed to a considerable physiological 
assault.   
In the present study, rSO2 was recorded in the upper arm only; for future 
work, it would be interesting to repeat the study using a second, more distal site to 
compare the effect of peripheral vaso-constriction on rSO2 readings taken further 
from the central circulation and over a different anatomical area.  Monitoring 





blood flow simultaneously would also add greater understanding of the value of 
rSO2 measurements as an indicator of poor perfusion. 
The low rSO2 readings combined with poor signal strength indication 
obtained for 1 of the volunteers suggested a poor connection at some point 
between the volunteer and the oximeter.  Replacing the NIRS sensor did not 
improve the readings obtained – although both discarded sensors subsequently 
appeared to function appropriately when applied to the upper arm of the principal 
investigator.  A review of the literature led to the suggestion that the darker skin 
pigmentation seen in the volunteer may have contributed to the  loss of signal, as 
melanin absorbs more of the near infra-red light emitted (Shuler et al, 2009).  
During their study, Wassenaar and Van den Brand (2005) attempted to record 
tissue oxygen saturation in the lower leg anterior compartment muscles of 17 
volunteers with dark skin pigmentation.  In the 28 sets of data obtained from the 
17 volunteers, the NIRS signal was lost in 2 sets where the tissue oxygen 
saturation was >50% and 12 sets where the tissue oxygen saturation was <50%.  
The mean melanin level of the volunteers in whom the NIRS signal was lost was 
greater than the melanin levels for the volunteers in whom the NIRS signal was 
not lost (p=0.012).  The authors suggested that higher melanin levels may affect 
the reliability and veracity of tissue oxygen saturation readings obtained.  
Certainly, within the current study, rSO2 levels were significantly lower and were 
excluded from the analysis as a result. 
A similar issue was identified with tattooed skin; several of the volunteers 
had large tattoos to the upper arm, covering the proposed monitoring site.  In these 
individuals, it was more difficult to obtain a reliable signal strength indication 





when monitoring through the tattoo.  As a solution, monitoring was undertaken in 
the opposite arm, or, in one case, the position of the monitoring sensor had to be 
slightly adjusted as the volunteer had tattoos to both upper arms.  The tattoos 
which incorporated coloured ink did not seem to cause an issue, but the black ink 
used in monochromatic designs such as illustrated in Figure 23 proved 
problematic.  Barker (2011) identified a comparable issue and concluded that the 
tattoo ink absorbed the near infra-red light in a manner similar to that described in 
dark pigmented skin. 
 
Figure 23. An example of a monochromatic tattoo to the upper arm 
 
 Conclusions: The aims of this additional experimental phase were met; 
changes in tissue oxygen saturation in response to LBNP, HAST and tilt were 
observed, but they demonstrated similar trends to those seen in response to the 
LBNP and HAST only combination, leading to the conclusion that the 70° head 
up tilt did not exacerbate the fall in rSO2 seen in the earlier experimental phase, as 
was anticipated.  Further investigation is recommended as this may have 
implications for the use of the monitoring system in trauma casualties.  The fact 





that peripheral oxygen saturation was maintained during these experimental 
conditions despite the significant changes seen in other physiological markers 
may be considered a positive when considering the safety of early aeromedical 
evacuation– although it must be remembered that this is not indicative of cerebral 
oxygenation which might display different trends under the same conditions.






7. AN INVESTIGATION OF CHANGES IN TISSUE 
OXYGEN SATURATION IN MILITARY CASUALTIES 
UNDERGOING AEROMEDICAL EVACUATION 
 
7.1. Methods 
Aim: During the second phase of this study, regional tissue oxygen 
saturation monitoring was demonstrated to be sensitive to changes occurring as a 
result of simulated alterations to altitude and circulating volume in healthy 
volunteers.  The main aim of this third phase of research was to undertake a 
prospective observational study to identify if changes in tissue oxygen saturation 
occur in military casualties during aeromedical evacuation from Afghanistan to 
the UK.  A secondary aim was to investigate whether there were more changes in 
tissue oxygen saturation in those casualties with lower pre-flight haemoglobin 
levels. 
  
Study protocol: The study protocol was submitted to and approved by the 
RAF Experimental Medicine Scientific Advisory Committee and the Ministry of 
Defence Research Ethics Committee (MoDREC reference 285/Gen/11).  CCAST 
personnel were briefed on the nature and format of the proposed study at their 
quarterly meeting.  
 
Subjects: Military casualties who sustained a significant traumatic injury 
whilst serving in Afghanistan, who required aeromedical evacuation back to 
RCDM for in-patient management were included in the study.  For the purpose of 
this study, a significant traumatic injury was defined as an ISS or NISS of 9 or 





greater (Appendix A).  A request for aeromedical evacuation for each casualty 
was raised by the in-theatre Aeromedical Evacuation Liaison Officer (AELO), as 
usual.  This request was sent to AECC personnel, who authorised the AE and 
arranged a suitable flight.  On receipt of an AE request for a critical care casualty, 
AECC personnel contacted the principal investigator to discuss whether the 
casualty met the study criteria.  Once a suitable casualty had been identified, the 
principal investigator travelled to RAF Brize Norton to join the CCAST members 
for the AE flight.  As all casualties included in the study were ventilated and 
sedated at the time of AE, informed consent was not obtained; however, 
agreement for inclusion in the study was obtained from the consultant anaesthetist 
responsible for the casualty in-flight.  As the tissue oxygen saturation monitoring 
did not impact on the casualty’s continuing care, nor alter his existing condition, 
retrospective consent was not sought from the casualties or their relatives.  The 
issue of not seeking retrospective consent was articulated in paragraph 14a of the 
study protocol submitted to, and approved by, MoDREC (MoDREC reference 
285/Gen/11).   
 
Monitoring technique: Continuous in-flight physiological monitoring of 
the casualties was undertaken by the CCAST escorts, using the MRL PIC 50 
monitor (WelchAllyn, New York), in accordance with existing CCAST protocols.  









Variable Measurement Technique 
Peripheral arterial oxygen saturation 
Heart rate 
Respiratory rate 
Invasive systolic/diastolic blood pressure 
End tidal carbon dioxide concentration 
Temperature 
Central venous pressure 
Tissue oxygen saturation 
MRL PIC 50 
MRL PIC 50 
MRL PIC 50 
MRL PIC 50 
MRL PIC 50 
MRL PIC 50 
MRL PIC 50 
INVOS 5100C Oximeter 
Table 30.  Measured variables recorded during aeromedical evacuation 
 All medical monitoring equipment undergoes a rigorous testing procedure 
before being approved for use in military aircraft.  Each item of equipment is 
tested to ensure that it is capable of operating in-flight as the manufacturer 
intended, despite being potentially exposed to altitude, vibration, sudden 
decompression, acceleration/deceleration forces and changes in temperature and 
humidity (Lamb, 2003).  Items are also tested to ensure that they do not have an 
adverse effect on the aircraft, such as electromagnetic interference (EMI); this is 
particularly important on-board a military aircraft which may have defensive aids 
fitted – any EMI may inadvertently activate these defensive aids, or affect other 
electrical systems, such as navigation or flight controls.  Nish et al (1989) 
previously reported a high incidence of neonatal monitoring equipment failing to 
meet United States Air Force EMI regulations.  Electromagnetic compatibility 
testing is also undertaken, to ensure that the aircraft and its systems do not affect 
the correct functioning of the medical monitoring devices (McGuire, 2006b).   
 
As tissue oxygen saturation monitoring was not a standard monitoring 
technique, there were no approved devices available for use in-flight.  The INVOS 
5100C cerebral/somatic oximeter underwent limited airworthiness testing to 
ensure that the device did not endanger the aircraft; as a result of the testing, 





temporary air clearance was issued permitting use of the monitor on board the C-
17 aircraft only, for a 6 month period.  A further request for a 3 month extension 
to the temporary air clearance was submitted to the C-17 Release to Service 
authority to permit an additional data collection period, which was approved.  The 
full airworthiness test schedule was not performed due to the trial nature of the 
study.  Likewise, the limited airworthiness testing was only undertaken for the C-
17 aircraft, as the majority of CCAST casualties are evacuated on this airframe; 
adding other aircraft to the test schedule would have prolonged the clearance 
process and increased the financial cost.   
 
 Data Collection: All monitoring devices were tested and used in 
accordance with the manufacturer’s instructions.  Prior to use on each casualty, 
the data log on the MRL PIC 50 was cleared, to ensure that only data pertaining to 
the current casualty was recorded.  The CCAST escorts connected the casualty to 
the MRL PIC monitor using the appropriate leads or transducers during retrieval 
from the Intensive Care Unit in the Field Hospital.  Although live continuous data 
was shown on the monitor’s screen, the MRL PIC was set to record readings of 
the physiological parameters to the internal data log every 5 minutes for the 
duration of the flight.  The readings were printed from the log at the end of the 
flight; the data was later exported into a Microsoft
©
 Office Excel file. 
To ensure standardisation in monitoring technique, the same methods were 
used for setting up the INVOS Oximeter and recording data as were described in 
chapters 5 and 6.  Due to the limited space around the casualty’s stretcher on-
board the aircraft, the INVOS monitor and cables were placed directly onto the 





aircraft floor and secured in place utilising strops and the ‘D’ ring securing points 
which are built into the floor. 
Once the casualty had been transferred to the aircraft, the INVOS 
Oximeter was switched on and the ‘new patient’ option selected from the start up 
screen, which reset the default parameters and started a new data log.  The INVOS 
Oximeter was then attached to the casualty, with the sensor placed on the lateral 
aspect of the upper third of the upper arm over the deltoid muscle.  The left upper 
arm was the preferred site, but this was dependent on the injuries sustained by the 
casualty and on direction from the consultant anaesthetist responsible for the 
casualty’s in-flight care.  Where required, the right upper arm was the alternative 
site used for monitoring.  Tissue oxygen saturation readings were recorded to an 
internal file every 6 seconds for the duration of the flight; these were later 
exported into a Microsoft
©
 Office Excel file.  Event markers were used to 
synchronise timings between the 2 sources.  Data reduction was achieved by 
calculating the mean rSO2 measurements for each 5 minute period of recording to 
permit comparison with the 5 minute readings of the other physiological variables 
obtained from the MRL PIC. 
CCAST personnel were blinded to the readings obtained from the INVOS 
to ensure that there were no in-flight changes in clinical management instigated in 
response to tissue oxygen saturation readings.  Data collection ended when the 
aircraft came to a stop on the designated stand at Birmingham International 
Airport.  Data from the MRL PIC was printed prior to the casualty being off-
loaded from the aircraft.  The casualty was disconnected from the INVOS monitor 





at this time, but the CCAST continued to use the MRL PIC to monitor the 
casualty’s condition during the road transfer to RCDM.       
A standardised data collection matrix was used to extract relevant data 
from the casualty’s hospital records.  This included: 
a. Mechanism of injury 
b. Injuries sustained 
c. Blood / blood replacement therapy post injury 
d. Pre-flight haemoglobin and haematocrit levels 
e. Clinical in-flight management parameters, such as ventilator settings, and 
the rate and type of sedation agents, inotropic support or fluid replacement 
therapy given. 
The anonymised data were stored in a Microsoft
©
 Excel spreadsheet which 
permitted calculation of specific descriptive statistics.  
Two audit requests were made for the release of additional post-flight data 
from the JTTR held by ADMEM at RCDM.  The first data request was for the 
post-flight haemoglobin and haematocrit levels (defined as the first results 
obtained on arrival at the receiving hospital) which were recorded during visits by 
the military trauma co-ordinator team and the second request was for the injury 
severity score for each casualty (see Appendix A) as calculated by the trauma co-
ordinator from the record of the casualty’s injuries. 
 
7.2. Results 
Tissue oxygen saturation monitoring was recorded in 15 casualties 
undergoing aeromedical evacuation from Afghanistan to the UK during the period 





January – August 2012.  All flights were successfully completed with no fatalities 
en-route.  A total of 147 monitoring hours were recorded, with a mean transfer 
time of 9.8 hours per casualty (range 8 to 13 hours).  The difference in flight times 
related to the route taken by each aircraft, with some returning direct to the UK 
and some making re-fuelling stops en-route.  All flights landed in Birmingham, 
where the casualties were off-loaded and transferred to RCDM. 
 
Demographics: All 15 casualties were male; the mean age was 25.2 years 
± 4.2 (range 21-38 years).  The majority of the casualties (n=10) had received 
traumatic injuries as a result of IED activation.  The mean ISS (±SD) was 37.1 ± 
22.5 (range 8-75) and the mean NISS (±SD) was 48.9 ± 19.1 (range 12-75).  
Three casualties had ISS and NISS scores of 75.  Mean cabin altitude was 
5933.3ft (range 3000-8000ft). 
 
Ventilation: All casualties had been ventilated and sedated during the 
initial management of their injuries and this was maintained during their 
aeromedical evacuation.  Seven of the casualties were ventilated using pressure 
control mode and 3 on volume control mode.  Five casualties began their flights 
on volume control mode but were changed to pressure control mode in-flight to 
reduce factors such as high airways pressure or a rising PCO2 level. 
The initial ventilator settings are shown in Table 31, with any in-flight 
changes made.  Excluding changes in mode of ventilation, there were 42 recorded 
alterations to the ventilator settings in-flight, averaging 0.28 changes per 
monitoring hour. 










Set tidal volume (mL) 557.3 ± 50.9 450 660   5 
Set respiratory rate (bpm)   16.8 ± 1.88   14   20 19 
Set PEEP (cm H2O)     5.6 ± 1.4     5   10   2 
Set FiO2      0.4 ± 0.06     0.3     0.5 16 
Table 31. Initial ventilator settings and in-flight changes 
PEEP = Peak end expiratory pressure; FiO2 = Fraction of inspired oxygen 
 
 As seen in phase 1, respiratory rate was the most commonly adjusted 
variable in-flight, with 19 changes seen in the current study, averaging 0.12 
changes per monitored hour (Table 32).  Six casualties ended the flight with a 
lower set respiratory rate, 1 with a higher set rate and 5 did not have any rate 
changes initiated.  Three casualties had rate changes in-flight but had returned to 
the original setting by the end of the evacuation. 
Fraction of inspired oxygen was the second most common change with a 
total of 16 changes in-flight; 10 casualties ended the flight with a lower FiO2, 3 
with a higher FiO2 and 2 with an unchanged FiO2.  The mean number of changes 
by monitored hour and per casualty was similar to those seen in the first phase of 












Tidal volume   5 0.3 0.03 0-3 
Respiratory rate 19 1.26 0.12 0-4 
PEEP   2   0.13 0.01 0-1 
FiO2  16   1.06 0.11 0-2 
Total Changes 42 2.8 0.28 1-5 
Table 32. Mean number of changes per casualty and per monitored hour 
 






 Sedation: Three different medications were used to maintain sedation in-
flight.  Eight casualties received a midazolam, propofol and fentanyl (or fentanyl 
derivative – alfentanil) combination, six casualties received a propofol and 
fentanyl combination and 1 casualty received midazolam with fentanyl.  In total, 
38 separate infusions were administered between the 15 casualties; the breakdown 
of changes in the medication administration rates is shown in Table 33.  In 9 
infusions, no rate changes were seen; in the remaining 29 infusions, there were a 




Rate Change Other Rate 
Changes
7
 Increase Decrease None 
Propofol (n=14) 3 8 2 1 
Fentanyl/Derivative (n=15) 4 6 3 2 
Midazolam (n=9) 2 0 4 3 
Table 33. Comparison of pre-flight and post-flight medication administration rates 
 
 
 Inotropic Support: Six casualties received noradrenaline infusions in-
flight.  There were a total of 14 changes in administration rates during the flight, 
averaging 2.3 changes per casualty.  By the end of the flight, 3 casualties were 
receiving higher doses than during the immediate pre-flight period and 3 
casualties were receiving lower doses. 
 
 Haemoglobin: Eleven casualties had a recorded pre-flight haemoglobin 
level below 10g/dL (range 7.5 – 9.9g/dL); pre-flight blood transfusions had been 
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administered to all of the casualties, although detailed information regarding 
transfusion amount was missing from 1 set of records.  A total of 113 units of 
blood (range 2-42 units; mean 11.3 units/casualty) and 101 units of FFP (range 2-
35 units; mean 10.1 units/casualty) had been transfused into 10 of these casualties 
in the time between injury and AE.   Five of these casualties received further 
blood products in-flight, with 10 units of blood (range 1-3; mean 2 units/casualty) 
and 3 units of FFP (range 0-1; mean 0.6 units/casualty) transfused during the 
flight. 
 The remaining 4 casualties had pre-flight haemoglobins levels above 
10g/dL (range 10.2 - 12.1g/dL).  Fifty four units of blood (range 0-34; mean 13.5 
units/casualty) and 58 units of FFP (range 0-36; mean 14.5 units/casualty) were 
transfused in the time between injury and transfer.  Only 1 of these casualties was 
transfused in-flight – receiving 2 units each of blood and FFP. 
 Of the 11 casualties with a pre-flight haemoglobin level below 10g/dL, 6 
had a higher post-flight level (all of which were above 10g/dL).  In the higher 
haemoglobin group, only one of the casualties had a lower haemoglobin level 
post-flight, but this was still above 10g/dL.  Figure 24 demonstrates the pre- and 
post-flight haemoglobin levels for each casualty.  





Figure 24. Pre- and post-flight haemoglobin levels by casualty 
 
 The results of a paired t-test comparing the pre and post-flight 
haemoglobin levels for the 15 casualties are shown below.  The mean post-flight 
haemoglobin level was over 1g/dL higher than the pre-flight level and, as in phase 
1, this was shown to be statistically significant (p=0.0013). 
Haemoglobin Mean Std Err Std Dev 95% Confidence Interval 
Pre Flight   9.4     0.3           1.2   8.7      10.0 
 
Post Flight  10.7**     0.4            1.5       9.9      11.5 
Difference  -1.3         0.3       1.3       -2.0       -0.6 
Table 34. The results of a paired t-test comparing pre- and post-flight haemoglobin levels in 
15 casualties 
** indicates p<0.01 compared to pre-flight value 
 
 Tissue oxygen saturation monitoring was undertaken in all 15 casualties; 
however, 1 set of results was not included in the final analysis as prolonged 
periods of the data collection was compromised due to poor adherence of the 
monitoring sensor on the casualty’s arm.  In the remaining 14 casualties, rSO2 





monitoring was performed in the deltoid muscle of the left or right upper arm, 
depending upon injury sites, with readings recorded every 6 seconds.  Several of 
the casualties had tattoos to the upper arm, and, following the lessons learned in 
phase 2, care was taken to ensure that data collection was not compromised from 
placing the monitoring sensor directly over the tattooed area – where possible, the 
other arm was used for monitoring.   
 
The data were reduced to the mean reading for each 5 minute period, with 
the first 5 minute period used as a baseline for comparison with later readings.  
Data from 4 of the 14 casualties (28.6%) demonstrated that the in-flight rSO2 
readings fell by more than 10% of the initial baseline reading recorded pre-flight, 
during at least 1 five minute period in the flight.  
  
Figure 25 demonstrates the mean rSO2 readings for the 14 casualties for 
each 5 minute period of monitoring throughout the duration of their flights.  To 
aid interpretation, the readings are shown across three graphs (0-245 minutes, 
250-495 minutes and 500 to 835 minutes).  Flight duration varied for each 
casualty depending on the route taken by each aircraft, with some returning direct 
to the UK and some making re-fuelling stops en route. 






Figure 25. Mean rSO2 readings in 14 casualties for each 5 minute period of monitoring for 
the duration of each flight. 





Amongst the four identified casualties, the readings fell by 11%, 12%, 
15% and 22% of the initial baseline reading respectively.  In all four cases, the 
rSO2 readings showed a gradual decline, over a period of time, rather than a steep 
or abrupt drop.  There appeared to be no pattern to the decline, with some of the 
casualties demonstrating a later recovery towards the baseline reading.  Analysis 
of the time to event data demonstrated that the start of all four reductions took 
place at different time points during the flight (Figure 26), ranging from 90 
minutes to 320 minutes.  The remaining ten casualties (71.4%) maintained rSO2 
readings within 10% of their individual baseline, until monitoring was completed 
at the end of each flight (range 485-600 minutes). 
 
Figure 26. Kaplan-Meier chart showing in-flight time to loss of ≥10% baseline rSO2 readings 
(4 from 14 casualties)  
 
 A review of all four casualties was undertaken in an attempt to identify the 
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sustained their injuries as a result of IED blast, although their actual injuries were 
different, both in location and severity.  Compared with the group who did not 
demonstrate any fall in rSO2, the ISS/NISS in this group was lower, as shown in 
Table 35.  However, there were 3 casualties who had sustained penetrating head 
injuries, which were subsequently awarded an ISS/NISS of 75, which skewed 
comparison of the trauma scores, as the rSO2 fall group did not contain any head 
injured casualties.  If the 3 head injured casualties were excluded, the results for 
the no rSO2 fall group reduced to ISS 30.1 (±13.4) and NISS 43.1 (±11.1).  A one-
way Kruskal-Wallis test was performed using the ISS/NISS by rSO2 fall or no fall 
group.  With a p-value >0.5, the results were not significant, demonstrating there 
was no evidence of a difference between the two groups.  The result was also not 
significant when the test was repeated with the ISS/NISS of the 3 head injured 
cases excluded. 
 No rSO2 fall observed 
(n=10) 
rSO2 fall observed 
 (n=4) 
















Three of the four casualties had received massive transfusions of blood 
products in the time between injury and aeromedical evacuation.  Transfusion data 
was not available for the fourth casualty, but it is likely that he would have 
received a sizeable transfusion, given the type and extent of the injuries suffered.  
As shown in Table 36, the mean transfusion volume per casualty was higher for 
those in whom an rSO2 fall was observed.  Again, the head injured patients 





slightly skewed this result as they tended to receive smaller transfusions than 
other casualty groups, as the actual blood loss they experienced as a result of their 
injury was generally less. 
 No rSO2 fall observed 
(n=10) 
rSO2 fall observed 
 (n=3) 




































Table 36. Comparison of blood and fresh frozen plasma administration in casualties with 
and without a fall in rSO2 readings 
 
In-flight clinical management changes were very similar amongst the 4 
casualties, with only minor adjustments to ventilation settings and sedation rates.  
Sedation rate changes are shown in Table 37 below.  
Medication 
Rate Change Other Rate 
Changes
8
 Increase Decrease None 
Propofol (n=3) 2 1 0 0 
Fentanyl/Derivative (n=4) 2 1 1 0 
Midazolam (n=2) 0 0 1 1 
Noradrenaline (n=1) 0 1 0 0 
Table 37. Comparison of pre- and post-flight medication administration rates in 4 casualties 
 
Respiratory rate was changed in 2 casualties, with one rate being reduced and one 
rate being altered but returning to pre-flight settings by the end of the flight.  In 3 
cases, the initial FiO2 setting was reduced during the flight.   
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A review of the physiological variables in the two groups was then 
undertaken.  The rSO2 trends for the four casualties demonstrating an in-flight fall 
were plotted against their heart rate, arterial oxygen saturation and systolic blood 
pressure readings to see if there were similar changes seen in these variables at the 
time the rSO2 readings were decreasing (Figures 27 to 30). 
 By inspection, there appeared to be little correlation between the changes 
in rSO2 readings and the other physiological variables.  In the main, SpO2 
readings barely changed for the duration of the four flights.  In cases 1 and 4, 
there is evidence of falling heart rate in response to rising blood pressure, which is 
possibly mediated by the baroreceptor reflex.   In cases 2 and 3, there is no clear 
relationship between heart rate and blood pressure, but other factors could be 
influencing heart rate response, including metabolic factors or therapeutic 
interventions.  In case 4, there appears to be an inverse relationship between rSO2 
and heart rate, although this is not as clear in cases 1 to 3.  The changes in case 4 
may reflect local vasoconstriction promoting a fall in rSO2. 
The timings of changes in ventilation or sedation management or other 
clinical care did not appear to directly correlate with the changes seen in rSO2.  
There were some brief downward trends in all four variables seen in case 4, 
particularly at 265 minutes and 425 minutes; these correspond to the timings of 
pressure area care provision, during which time the casualty was being rolled 
from side to side, affecting all variables.  When the monitored arm was 
uppermost, a fall in rSO2 was clearly seen, which resolved once the casualty was 
supine. 
  






Figure 27. Comparison of mean 5 minute intervals of heart rate, blood pressure, rSO2 and 




Figure 28. Comparison of mean 5 minute intervals of heart rate, blood pressure, rSO2 and 
SpO2 for Case 2 
 





Figure 29. Comparison of mean 5 minute intervals of heart rate, blood pressure, rSO2 and 




Figure 30. Comparison of mean 5 minute intervals of heart rate, blood pressure, rSO2 and 
SpO2 for Case 4 
 
 





 The results from in-flight arterial blood gas samples were also reviewed, to 
investigate whether any trends in changes to lactate, pH and base excess could be 
observed to compare with the trends seen in rSO2 monitoring.  However, in the 4 
cases in question, arterial blood gases were sampled infrequently throughout the 




Summary: Tissue oxygen saturation monitoring was undertaken in all 15 
casualties, without significant incident.  The inability of the monitoring sensor to 
adhere to the upper arm of one casualty is thought to be linked to the condition of 
the casualty’s skin – most likely that the casualty’s skin was moist as a result of 
the mild pyrexia observed during the flight.  The monitoring system performed 
well at altitude and no interactions between the aircraft and the monitor were seen. 
The different flight profiles utilised during the various flights added 
further complexity to the data analysis as some casualties were exposed to 
additional changes in the partial pressure of alveolar air during the en-route 
descents and ascents pre- and post-refuelling.  Likewise, the wide range of cabin 
altitudes experienced during the different flights meant that some casualties were 
exposed to higher altitudes than others, providing an additional confounder when 
comparing the results obtained.  
In 10 cases, there was little change in tissue oxygen saturation readings 
throughout the flights.  In the 4 cases where > 10% fall in readings was observed, 
the changes happened at different points in the flight and at a time when the 
aircraft was in the cruise – not specifically during the ascent or descent elements 





as had been anticipated pre-study.  In explaining these decreases in tissue oxygen 
saturation, a number of confounders must be considered.  These casualties had 
been exposed to significant trauma and blood loss for which they required fluid 
resuscitation and damage control surgery.  They had received large transfusions of 
blood and blood products prior to flight and continued to receive some products 
in-flight.  Other clinical management protocols were in progress, including 
mechanical ventilation, and the use of sedation and inotropes to maintain and 
improve the casualty’s condition throughout the flight.  The body’s immediate 
response to traumatic injury is to initiate vasoconstriction of the vessels, to 
prevent further blood loss and to maintain central perfusion.  Once fluid 
resuscitation is achieved, the body undergoes a period of vasodilatation to restore 
blood flow and oxygen supply to all areas of the body (Brøchner and Toft, 2009).  
In addition to this reaction, the body also initiates an immunological response to 
the traumatic injury and to the blood transfusions used to counter the initial 
hypovolaemia, which may have an effect on peripheral perfusion.  Added to all of 
these factors, the casualties have then been exposed to the effects of changing 
altitude.  With so much activity at the cellular level, the mechanism behind the 
reductions in tissue oxygen saturation is not clear, particularly when other 
casualties, with potentially more severe injuries, who were also exposed to these 
same factors, did not experience the same reductions.   
 
Discussion: The changes observed in tissue oxygen saturation did not 
seem to occur in conjunction with changes in other physiological variables.  
However, Scheeren et al (2012) identify that vasoconstriction in response to 





hypovolaemia or other physiological assault may lead to reduced peripheral 
perfusion, (which could potentially be seen in lower rSO2 readings) even though 
systemic indicators, such as systolic blood pressure or heart rate, remain within 
normal limits.  Once the compensatory response to the physiological assault was 
exhausted, then the systemic indicators would begin to demonstrate compromise.  
Within the current study, it is hypothesised that the on-going clinical management 
(such as fluid / blood / inotrope administration, and mechanical ventilation) of the 
casualties prior to, and during their flights may have reversed the deterioration in 
their physical condition before systemic responses were identified.  As peripheral 
perfusion improved, so the rSO2 readings also improved.  Oedema in damaged 
tissues as a result of traumatic injury could also lead to reduced peripheral 
perfusion due to higher tissue pressures (Schober and Schwarte, 2012), which 
could potentially be observed in a trend of falling rSO2 readings, although direct 
readings over traumatised tissue were not undertaken in this study.  Alternatively, 
given that the casualties were all repatriated within 12-24 hours of the injury, the 
low rSO2 readings could have been the ‘tail-end’ of the initial response to the 
trauma, with the systemic responses having been managed and the peripheral 
tissues now returning to normal perfusion and therefore restoring oxygenation.  
As rSO2 monitoring was only instigated when the casualty arrived at the aircraft, a 
comparison with earlier readings was not possible.  
Interestingly, in their 2013 paper, Dubost et al monitored minute-by-
minute heart rate and stroke volume to calculate cardiac index in military 
casualties undergoing aeromedical evacuation.  During the ten minute period from 










despite the fact that heart rate did not change throughout the entire period.  A 
reduction in cardiac index may lead to a loss of peripheral perfusion even though  
there were no overt signs in systemic readings (heart rate).  A similar response 
was seen in the current study, in that changes in tissue oxygen saturation were 
observed but other systemic physiological variables such as SpO2 or heart rate did 
not change.  This suggests that monitoring of systemic variables may not provide 
the whole picture regarding the casualty’s clinical condition.   
The remaining 10 casualties did not demonstrate any meaningful decreases 
in tissue oxygen saturation throughout their flights, suggesting that adequate   
peripheral oxygenation was maintained throughout the aeromedical evacuation.  
The phase 2 volunteers experienced greater changes in tissue oxygen saturation 
during exposure to LBNP and HAST; however the experimental conditions 
simulated hypovolaemia, which should have been corrected in the casualties by 
the time they were emplaned, perhaps explaining why smaller changes in readings 
were observed.  The earlier work identified that rSO2 was sensitive to changes in 
clinical condition, so it could be suggested that clinically stable casualties might 
not demonstrate any in-flight decreases in rSO2 readings.  
 The clinical significance of the decreases in rSO2 readings seen in 4 
casualties is not fully understood.  As the end point for the current study was the 
conclusion of the aeromedical evacuation flight, clinical outcomes for the 
casualties were not captured, so it is unknown whether these individuals 
experienced negative sequelae.  However, as previously discussed, other studies 
have identified tissue oxygen saturation monitoring as a potential early indicator 
for the development of multiple organ dysfunction syndrome (Cohn et al, 2007) 





and as an indicator for effective traumatic shock resuscitation (McKinley et al, 
2000), so further work is required to understand the clinical significance of any 
decreases in in-flight tissue oxygen saturation.    
 
Limitations: The original aim was to recruit 30 casualties to the study to 
provide sufficient data from which to draw some conclusions; however, the 
casualty numbers seen at the beginning of 2012 fell significantly compared with 
the same time period in earlier years.  The actual data collection period was 
extended by 3 months in an attempt to meet the sample size; however, casualty 
rates remained low and this was not achieved. 
Additional data sources were also sought from other NATO allies; and, in 
principle, agreement was obtained.  However, the complexities of a UK researcher 
collecting data on non-UK casualties, combined with the extended period required 
to obtain host nation ethics approval and flight clearance for the monitoring 
system made this an unworkable solution. 
 
Conclusion: The aim of this third phase of the study was to undertake a 
prospective observational study to identify if changes in tissue oxygen saturation 
occur in military casualties during aeromedical evacuation from Afghanistan to 
the UK.  The study did identify changes in tissue oxygen saturation in some of the 
trauma casualties during repatriation to RCDM, Birmingham.  The changes 
observed ranged from 11-22% decrease in saturation during in-flight monitoring, 
although it is not clear that these changes were a direct result of the aeromedical 
evacuation.  However, with only four sets of data to analyse, any meaningful 





conclusions become difficult to justify.  Having identified that changes do occur 
though, further work is required to investigate the cause and severity of these 
changes and to develop some potential management/treatment techniques.  
Additionally, no casualties experienced serious clinical deterioration in flight, so it 
was not possible to determine how rSO2 might have responded or been useful in 
identifying this scenario.    
A secondary aim was to investigate whether there were more changes in 
tissue oxygen saturation in those casualties with lower pre-flight haemoglobin 
levels.  As seen in phase 1, the haemoglobin status of the casualties was obscured 
by the additional confounders encountered during data analysis.  Since the 
majority of casualties demonstrated a higher post-flight haemoglobin level, this 
might suggest that the risk of anaemic hypoxia had been addressed pre-flight 
through appropriate transfusion of blood and blood products.   
        
 
       





8. DISCUSSION / RECOMMENDATIONS 
 
The overall aim of this study was to investigate changes in tissue oxygen 
saturation in military casualties during aeromedical evacuation.  Military 
casualties injured during recent operations in both Iraq and Afghanistan have 
often sustained extensive traumatic injuries, the degree of which is rarely seen in 
civilian practice.  As a result of these emerging injury patterns, new treatment 
protocols for the immediate management and resuscitation of the casualties have 
been developed.  The success of these protocols has meant there are larger 
numbers of severely injured personnel surviving the initial injury, who require 
aeromedical evacuation to the UK for on-going medical management.  As these 
casualties are often flown home within hours of their primary injury, they are 
generally still in the early stages of treatment, having received immediate 
resuscitation care, followed by damage control surgery.  This rapid evacuation 
system means that casualties are still receiving medical treatment to correct issues 
such as acidosis or fluid loss whilst being exposed to the additional hazards of 
flight, including altitude and pressure changes.  There is little evidence within the 
literature that the combined effects of these factors have been considered. 
 
 Findings: Phase 1 of the study was a retrospective review of the in-flight 
records for 27 military casualties undergoing aeromedical evacuation following 
significant traumatic injury.  The review identified a number of in-flight changes 
in clinical condition and management, although, as a retrospective review, it was 
not possible to attribute the changes to a specific cause.  However, the severity of 
the casualties’ injuries and the complex medical management required in-flight to 





maintain a stable condition were evident from the review.  Systemic physiological 
monitoring did not demonstrate any gross changes in clinical condition as a result 
of early aeromedical evacuation.  
 Phase 2 of the study sought to validate the technique of tissue oxygen 
saturation monitoring, using near infra-red spectroscopy, at simulated altitude.  
Healthy volunteers were exposed to a hypoxia altitude simulation test and/or a 
lower body negative pressure test to investigate whether the monitoring system 
could identify changes in tissue oxygen saturation induced by a simulated altered 
circulating volume and/or altitude up to 8,000 feet.  The results showed that 
regional tissue oxygen saturation was the only monitoring technique to 
demonstrate an effect in response to all 3 test conditions, suggesting that it may be 
more sensitive to changes than standard physiological monitoring and proving that 
it would be a suitable technique for use in phase 3 of the study. 
The aim of the third phase of the study was to investigate whether changes 
in tissue oxygen saturation occurred in military casualties during aeromedical 
evacuation.  The timing of the study coincided with the draw-down of combat 
operations in Afghanistan, leading to a reduction in the numbers of casualties 
compared with previous years, so data collection was limited to fifteen casualties.  
In four of those casualties, a fall in rSO2 readings of between 11% and 22% was 
observed during the flights, compared with a pre-flight baseline.  Due to the small 
sample size and the number of confounding variables, it was unclear whether 
these changes occurred as a result of the increased altitude or as a result of the 
casualty’s clinical condition and/or medical treatment received – or even as a 
combination of these factors.  However, decreases in tissue oxygen saturation 





were apparent, in some casualties, during the flight.  The longer term 
consequences of these decreases were not examined in the current study, so 
further work is required to determine the significance of these observed changes.   
 
Future work: Having identified that some casualties do experience periods 
of lower regional tissue oxygen saturation in-flight, there exists a requirement for 
follow-on studies, to investigate these findings further.  Even with the end of 
combat operations in Afghanistan imminent, the Royal Air Force Medical 
Service, like its international counterparts, continues to repatriate severely ill and 
injured military personnel from around the world.  Even if only a small percentage 
of the casualties experience reduced tissue oxygenation, this may have 
implications for their future management or even outcome.  As outlined in the 
preceding chapters, lower tissue oxygen saturation has been shown to be an early 
indicator of increasing hypovolaemia (Soller et al, 2008b), a marker for those 
patients likely to develop multiple organ dysfunction syndrome or die following 
trauma (Cohn et al, 2007) and a guide to identify those trauma patients who 
require early blood transfusions (Smith et al, 2008).  If, in future work, tissue 
oxygen saturation can be used to identify poor perfusion in local tissues after 
trauma (as a result of exposure to altitude or as a result of low haemoglobin levels, 
for example), it may be possible to treat the poor perfusion earlier and reduce the 
number of casualties who later require repeated wound debridement or amputation 
(as suggested by Hannah and Rice, 2013), or go on to develop organ failure.  A 
comparison of tissue oxygen saturation readings with blood flow monitoring 





(using plethysmography, for example), would confirm whether rSO2 readings are 
actually a predictor of poor perfusion. 
An end-to-end study would be required, to record tissue oxygen saturation 
from point of injury (or as close as possible) through the aeromedical evacuation 
to the point of discharge from intensive care, to observe outcomes in this casualty 
group.  This will also provide more in-depth understanding of rSO2, its 
applications and its sensitivity compared with the standard physiological 
monitoring currently in use.  A control group of casualties who did not undergo 
aeromedical evacuation would provide further information about the effects of 
altitude on tissue oxygen saturation.  Even as operations in Afghanistan come to a 
close, this information may be relevant for future conflicts, or even to civilian 
settings.  Tissue oxygen saturation data obtained in a fixed wing aircraft with a 
cabin altitude restriction of 2,000 feet, for example, may provide lessons for the 
management of civilian trauma casualties transported in an unpressurised 
helicopter at similar altitudes.  Likewise, information obtained in civilian practice 
would help to develop military practice appropriately.    
      One final recommendation as a result of the lessons identified during this 
study is the requirement for greater visibility of aeromedical evacuation research.  
Notwithstanding military sensitivities or commercial restrictions, sharing research 
data helps to improve casualty care for all.  It was identified that several abstracts 
from oral presentations discussed the use of tissue oxygen saturation monitoring 
during air medical (helicopter) transport (Guyette et al, 2008; Brywczynski et al, 
2009), but follow-on articles to develop the abstracts and support the presentations 
could not be located, suggesting that either they were not written or not published. 
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INJURY SEVERITY SCORE 
1. Records for all UK military trauma casualties are returned to ADMEM 
where the listed injuries are coded using the Abbreviated Injury Scale (AIS) – a 
method of ranking and comparing injuries which was originally developed by the 
Association for the Advancement of Automotive Medicine during the 1960s.  AIS 
is defined as “an anatomically-based, consensus derived, global severity scoring 
system that classifies each injury by body region according to its relative 
importance on a 6-point ordinal scale” (p.8) (Gennarelli and Wodzin, 2007). 
2. Each injury is assigned to a specific code from the AIS dictionary, which 
relates to a defined body region, anatomical structure and type of injury.  A 
severity number is also assigned to each code, according to the severity of that 
specific injury in an ‘average’ patient.  The level of severity ranges from 1 (minor) 
to 6 (maximum). 
a. As an example, a fracture of the head of femur is assigned the code 
853171.3 
 
b. This code is constructed from the following points: 
8 – Body region (lower extremity) 
5 – Structure type (skeletal) 
31 – Specific structure (proximal femur) 
71 – Level of injury (femoral head) 
3 – Severity number (serious) 
 
3. Baker et al (1974) later used the AIS coding system to develop the Injury 
Severity Score (ISS), which allowed an assessment of the severity of the injuries 
suffered by a poly trauma casualty.  To calculate the ISS, the body is divided into 
6 regions: 





a. Head or neck 
b. Face 
c. Chest 
d. Abdominal or pelvic contents 
e. Extremities or pelvic girdle 
f. External (body surface) 
 
4. The ISS is the sum of the squares of the highest AIS severity codes in each 
of the three most severely injured ISS body regions.  Only 3 codes are used to 
calculate ISS, even if the casualty has suffered 10 different injuries.  The ISS 
ranges from 1 to 75; a score of 75 is considered to be incompatible with life.  Any 
casualty suffering an injury which is coded with a severity number of 6 
(maximum) is automatically assigned an ISS of 75.  A casualty with an ISS of 16 
or greater is considered to have suffered major trauma, as a result of the 10% 
mortality rate seen in casualties who score an ISS of 16 (Russell et al, 2011). 
5.   The New Injury Severity Score (NISS) was developed by Turner et al 
(1997) in an attempt to improve the existing system.  All injuries are coded using 
the AIS dictionary as before, but the NISS is calculated from the 3 highest 
severity codes, irrespective of the body region; this system attempts to account for 
the casualty who sustains multiple injuries in one body region, whose injury 
severity is potentially underscored by ISS. 
6. ISS and NISS are calculated for all casualty records returned to ADMEM; 
for the purpose of this study, a significant injury is defined as an ISS or NISS of 9 
or more, which allows the inclusion of isolated limb trauma, such as a single 
lower leg amputation, which can cause considerable blood loss and require 
transfusion therapy, making these casualties relevant to the study.  







McLeod J. (2013) An investigation of changes in tissue oxygen saturation during 
exposure to altitude and lower body negative pressure.  Aviat Space Environ Med, 
84 (4): 366 [Abstract 299] 
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 Introduction: UK military personnel injured in an operational setting will 
often have sustained significant haemorrhage at the time of injury and may have 
undergone lengthy surgical procedures, receiving massive transfusions of 
blood/blood products.  The potential effects of early aeromedical evacuation 
combined with a reduced / altered haemoglobin status on tissue oxygenation and 
viability are not fully understood.  Near infra-red spectroscopy has been used to 
develop methods of monitoring regional tissue oxygen saturation (rSO2) although 
its potential use has not been evaluated in the aeromedical evacuation context.  
This study was undertaken as a pre-cursor to an in-flight observational study in 
military casualty populations.  Methods: Twelve healthy volunteers were 
subjected to 3 separate tests: 1) Hypoxia altitude simulation test (HAST) using 
15.1% oxygen mix to simulate a cabin altitude of 8,000ft, 2) Lower body negative 
pressure (LBNP) at 3 increments to simulate an altered circulating volume, and 3) 
HAST and LBNP combined.  A device utilising near infra-red spectroscopy 
(NIRS) was used to record deltoid muscle rSO2 in conjunction with standard 
physiological monitoring in these volunteers.  Results: Multivariate regression 
models were fitted to explain changes in pulse oximetry, heart rate, cardiac 
output, mean arterial pressure and regional tissue oxygen saturation in terms of 
simulated altitude and simulated altered circulating volume.  Deltoid rSO2 proved 
to be the physiological measure most responsive to each experimental condition.  
Discussion: The NIRS monitoring technique proved sensitive in identifying 
changes in rSO2 in response to the environmental and physiological conditions 
anticipated during aeromedical evacuation. 
 
Learning Objective: 
1. To understand the effects of simulated altitude and simulated altered 
circulating volume on regional tissue oxygen saturation in healthy volunteers. 
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McLeod J. and Green NDC. (2015) An investigation of changes in tissue oxygen 
saturation in military casualties during aeromedical evacuation [Abstract 86] 
 
Presented at the 63
rd
 International Congress of Aviation and Space Medicine, 
20-24 September 2015, Oxford, UK 
 
 Introduction: UK military personnel injured in an operational setting will 
often have sustained significant haemorrhage at the time of injury and may have 
undergone lengthy surgical procedures, receiving massive transfusions of 
blood/blood products.  The potential effects of early aeromedical evacuation 
combined with a reduced haemoglobin (Hb) status on tissue oxygenation and 
viability are not fully understood.  A near infra-red spectroscopy (NIRS) 
technique has been developed to monitor regional tissue oxygen saturation (rSO2) 
in the aeromedical evacuation setting.  Methods: rSO2 was recorded in the deltoid 
muscle of 15 ventilated military casualties during aeromedical evacuation from 
Afghanistan, together with standard critical care physiological variables.  The 
casualties had all experienced significant traumatic injuries, requiring damage 
control surgery and/or massive transfusions of blood/blood products.  Results: 
Deltoid rSO2 fell by ≥ 10% in 28% of the casualties, despite the absence of a 
significant corresponding change in systemic physiological variables, such as 
pulse oximetry or heart rate, or overt clinical deterioration. There was no 
relationship between transfusion status and rSO2 response.  Discussion:  This 
study suggests that patients with reduced Hb do not experience a greater degree of 
tissue hypoxia in flight.  A definitive role for rSO2 monitoring to identify 
clinically significant physiological changes in flight has not yet been established.  







The following stacked graphs demonstrate the mean physiological 
readings recorded in the 12 volunteers during the final minute of each phase of the 
experimental condition shown.  Figures 31 and 32 display the results from the 
hypoxia altitude simulation test; Figures 33 and 34 show the results from the 
lower body negative pressure, and Figures 35 and 36 demonstrate the results of 
the hypoxia altitude simulation test in conjunction with the lower body negative 
pressure test. 
Cardiac output was not recorded in subjects A and C during the hypoxia 
altitude simulation test as it was a late inclusion in the data collection protocol.  
Cardiac output was not recorded in subject A during the lower body negative 
pressure test, for the same reason.  Data recording failed during the hypoxia 
altitude simulation test for subject B, so data were not included in Figures 31 and 
32.   









Figure 31. Mean physiological readings for the final minute of each phase of the 
experimental condition recorded in 12 volunteers during hypoxia altitude simulation test 
a) Peripheral arterial oxygen saturation, b) heart rate, and c) tissue oxygen saturation. 








Figure 32. Mean physiological readings for the final minute of each phase of the 
experimental condition recorded in 12 volunteers during hypoxia altitude simulation test 
d) Mean arterial pressure, e) respiration rate, and f) cardiac output 
 
 









Figure 33. Mean physiological readings for the final minute of each phase of the 
experimental condition recorded in 12 volunteers during lower body negative pressure test 
a)Peripheral arterial oxygen saturation, b) heart rate, and c) tissue oxygen saturation 
 








Figure 34. Mean physiological readings for the final minute of each phase of the 
experimental condition recorded in 12 volunteers during lower body negative pressure test 
d) Mean arterial pressure, e) respiration rate, and f) cardiac output 









 (c)  
Figure 35. Mean physiological readings for the final minute of each phase of the 
experimental condition recorded in 12 volunteers during hypoxia altitude simulation test 
with lower body negative pressure test 
a) Peripheral arterial oxygen saturation, b) heart rate, and c) tissue oxygen saturation 








Figure 36. Mean physiological readings for the final minute of each phase of the 
experimental condition recorded in 12 volunteers during hypoxia altitude simulation test 
with lower body negative pressure test 
d) Mean arterial pressure, e) respiration rate, and f) cardiac output 
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The following stacked graphs demonstrate the mean physiological 
readings recorded in the 11 volunteers during the final minute of each phase of the 
experimental condition shown.  Figures 37 and 38 show the results from the lower 
body negative pressure, and Figures 39 and 40 demonstrate the results of the 
hypoxia altitude simulation test in conjunction with the lower body negative 
pressure test and a 70 degree head up tilt. 
Two values for cardiac output are missing for subject C in Figure 38(e) 
due to equipment failure during recording.  Respiratory rates were not recorded 
during the recovery phase of either experimental condition, as the majority of the 
volunteers couldn’t tolerate the mask.  Tissue oxygen saturation readings for 
subject D were excluded from both Figures 38(f) and 40(f) due to low rSO2 
readings combined with poor signal strength indication thought to be related to 
skin pigmentation issues, as discussed in Chapter 6.  










 (c)  
Figure 37. Mean physiological readings for the final minute of each phase of the 
experimental condition recorded in 11 volunteers during hypoxia altitude simulation test 
with lower body negative pressure test 
a) Peripheral arterial oxygen saturation, b) heart rate, and c) respiratory rate  








Figure 38. Mean physiological readings for the final minute of each phase of the 
experimental condition recorded in 11 volunteers during hypoxia altitude simulation test 
with lower body negative pressure test 
d) Mean arterial pressure, e) cardiac output, and f) tissue oxygen saturation  





HYPOXIA ALTITUDE SIMULATION TEST COMBINED WITH LOWER BODY 
NEGATIVE PRESSURE AND 70 DEGREE HEAD UP TILT 
 (a)
(b)
 (c)  
Figure 39. Mean physiological readings for the final minute of each phase of the 
experimental condition recorded in 11 volunteers during hypoxia altitude simulation test 
with lower body negative pressure test and 70 degree head up tilt 
a) Peripheral arterial oxygen saturation, b) heart rate, and c) respiratory rate  
 








Figure 40. Mean physiological readings for the final minute of each phase of the 
experimental condition recorded in 11 volunteers during hypoxia altitude simulation test 
with lower body negative pressure test and 70 degree head up tilt 
d) Mean arterial pressure, e) cardiac output, and f) tissue oxygen saturation  
 
 














































© Crown Copyright / MoD 2014 
 
Published with the permission of the Controller of Her Britannic 
Majesty’s Stationary Office. 
